[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 562
1. Leithner A, Gapp M, Radl R, Pascher A, Krippl P, Leithner K, Windhager R, Beham A: Immunohistochemical analysis of desmoid tumours. J Clin Pathol; 2005 Nov;58(11):1152-6
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunohistochemical analysis of desmoid tumours.
  • BACKGROUND/AIMS: Although the standard treatment for desmoid tumours is complete surgical resection with wide margins, the optimal adjuvant treatment for recurrent or inoperable disease is unclear, often being based on sporadic immunohistochemical reports with a low number of cases.
  • METHODS: One hundred and sixteen tissue samples from 80 patients (49 female, 31 male; mean age, 34 years; range, 0-83) with desmoid tumours (46 extra-abdominal, 21 abdominal, 13 intra-abdominal) were tested for oestrogen receptors alpha and beta, progesterone and androgen receptors, and somatostatin, in addition to HER2, cathepsin D, Ki-67, and c-KIT by immunohistochemistry.
  • Positive staining for the androgen receptor was found in six extra-abdominal cases.
  • Staining for oestrogen receptor beta was positive in four extra-abdominal, two abdominal, and one intra-abdominal case.
  • Staining for somatostatin was positive in six extra-abdominal, two abdominal, and one intra-abdominal case, and staining for cathepsin D was positive in all cases.
  • Positive staining for Ki-67 was found in 14 extra-abdominal, three abdominal, and three intra-abdominal cases.
  • C-KIT was detectable in one abdominal case only.
  • CONCLUSIONS: The data from this immunohistochemical study show that the published effects of antioestrogens and imatinib mesylate in the treatment of aggressive fibromatoses may not be attributable to oestrogen receptor alpha or c-KIT expression.
  • [MeSH-major] Biomarkers, Tumor / analysis. Fibromatosis, Aggressive / metabolism. Soft Tissue Neoplasms / chemistry
  • [MeSH-minor] Abdominal Neoplasms / chemistry. Abdominal Neoplasms / drug therapy. Abdominal Neoplasms / pathology. Adolescent. Adult. Aged. Aged, 80 and over. Cathepsin D / analysis. Chemotherapy, Adjuvant. Child. Child, Preschool. Female. Humans. Infant. Infant, Newborn. Ki-67 Antigen / analysis. Male. Middle Aged. Neoplasm Proteins / analysis. Proto-Oncogene Proteins c-kit / analysis. Receptors, Androgen / analysis. Receptors, Estrogen / analysis. Receptors, Progesterone / analysis. Somatostatin / analysis

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 2002 Dec 1;95(11):2373-9 [12436445.001]
  • [Cites] J Pediatr Orthop. 1992 Jan;12(1):1-10 [1732285.001]
  • [Cites] Am J Clin Pathol. 2003 Mar;119(3):339-45 [12645334.001]
  • [Cites] Dis Colon Rectum. 2004 Jan;47(1):118-22 [14719159.001]
  • [Cites] Cancer. 2004 Feb 1;100(3):612-20 [14745880.001]
  • [Cites] J Surg Oncol. 2004 Jun 1;86(3):152-6 [15170654.001]
  • [Cites] Virchows Arch. 2004 Aug;445(2):142-50 [15232741.001]
  • [Cites] J Bone Joint Surg Br. 1979 Aug;61-B(3):373-7 [479262.001]
  • [Cites] Cancer Res. 1980 Mar;40(3):861-5 [6258789.001]
  • [Cites] Surgery. 1981 Aug;90(2):149-53 [6266058.001]
  • [Cites] Am J Clin Pathol. 1982 Jun;77(6):681-5 [7091048.001]
  • [Cites] Am J Surg. 1986 Feb;151(2):230-7 [3946757.001]
  • [Cites] Lab Invest. 1986 Jun;54(6):689-94 [2423779.001]
  • [Cites] Eur J Cancer Clin Oncol. 1986 May;22(5):583-7 [3770030.001]
  • [Cites] Ann Surg. 1989 Dec;210(6):765-9 [2531573.001]
  • [Cites] Aust N Z J Surg. 1999 Nov;69(11):782-9 [10553966.001]
  • [Cites] Clin Orthop Relat Res. 2000 Jun;(375):207-13 [10853171.001]
  • [Cites] Am J Surg Pathol. 2000 Jul;24(7):947-57 [10895817.001]
  • [Cites] Mod Pathol. 2000 Oct;13(10):1134-42 [11048809.001]
  • [Cites] Clin Orthop Relat Res. 2001 Jan;(382):59-65 [11154005.001]
  • [Cites] Am J Surg Pathol. 2001 Apr;25(4):549-50 [11257638.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 1993 Jan;25(1-3):191-9 [8436465.001]
  • [Cites] Surgery. 1993 Nov;114(5):902-6 [8236012.001]
  • [Cites] Histopathology. 1997 Oct;31(4):336-41 [9363449.001]
  • [Cites] Am J Gastroenterol. 1999 Feb;94(2):530-2 [10022664.001]
  • [Cites] Cancer Res. 2001 Apr 1;61(7):3171-5 [11306504.001]
  • [Cites] Pathol Res Pract. 2001;197(11):775-9 [11770022.001]
  • [Cites] Anticancer Res. 2001 Sep-Oct;21(5):3615-20 [11848532.001]
  • [Cites] Am J Clin Pathol. 2002 Feb;117(2):188-93 [11865845.001]
  • [Cites] J Clin Oncol. 2002 Mar 15;20(6):1692-703 [11896121.001]
  • [Cites] J Pathol. 2002 Jun;197(2):155-62 [12015738.001]
  • [Cites] Curr Treat Options Oncol. 2000 Aug;1(3):262-6 [12057169.001]
  • [Cites] Acta Orthop Scand. 2002 Apr;73(2):213-9 [12079022.001]
  • [Cites] Lancet. 1992 Jan 4;339(8784):1-15 [1345950.001]
  • [Cites] Br J Cancer. 2003 Mar 10;88(5):645-7 [12618868.001]
  • (PMID = 16254103.001).
  • [ISSN] 0021-9746
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Ki-67 Antigen; 0 / Neoplasm Proteins; 0 / Receptors, Androgen; 0 / Receptors, Estrogen; 0 / Receptors, Progesterone; 51110-01-1 / Somatostatin; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit; EC 3.4.23.5 / Cathepsin D
  • [Other-IDs] NLM/ PMC1770757
  •  go-up   go-down


2. Chugh R, Wathen JK, Patel SR, Maki RG, Meyers PA, Schuetze SM, Priebat DA, Thomas DG, Jacobson JA, Samuels BL, Benjamin RS, Baker LH, Sarcoma Alliance for Research through Collaboration (SARC): Efficacy of imatinib in aggressive fibromatosis: Results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial. Clin Cancer Res; 2010 Oct 1;16(19):4884-91
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Efficacy of imatinib in aggressive fibromatosis: Results of a phase II multicenter Sarcoma Alliance for Research through Collaboration (SARC) trial.
  • PURPOSE: Aggressive fibromatoses (AF; desmoid tumors) are rare clonal neoplastic proliferations of connective tissues that can be locally aggressive despite wide surgical resection and/or radiation therapy.
  • EXPERIMENTAL DESIGN: Patients ≥10 years old with desmoid tumors that were not curable by surgical management or in whom curative surgery would lead to undesirable functional impairment were eligible.
  • Tissue specimens were analyzed by immunohistochemistry for expression of cKIT, platelet-derived growth factor receptor α (PDGFRα), PDGFRβ, AKT, PTEN, FKHR, and β-catenin.
  • Tumor DNA was analyzed for PDGFRα exon 18 and APC mutations by allelic discrimination PCR.
  • Expression and polymorphisms of target proteins were identified in tissue samples, but no significant correlation with outcome was observed using the samples available.
  • CONCLUSION: Imatinib may have a role in the management of unresectable or difficult to resect desmoid tumors.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Fibromatosis, Aggressive / drug therapy. Piperazines / therapeutic use. Pyrimidines / therapeutic use


3. Greenberg JA, Somme S, Russnes HE, Durbin AD, Malkin D: The estrogen receptor pathway in rhabdomyosarcoma: a role for estrogen receptor-beta in proliferation and response to the antiestrogen 4'OH-tamoxifen. Cancer Res; 2008 May 1;68(9):3476-85
Hazardous Substances Data Bank. ESTRADIOL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children.
  • Highly malignant, RMS frequently fails to respond to conventional aggressive multimodal radiation, surgery, and chemotherapy treatment protocols that also cause significant sequelae in the growing child.
  • Other tumors of mesenchymal origin, such as locally aggressive fibromatoses and desmoid tumors, have been successfully treated with a selective estrogen receptor (ER) modulator, tamoxifen.
  • In an effort to identify new targets for RMS therapy, our group investigated the previously uncharacterized ER pathway in RMS cell culture and primary tumors.
  • Immunohistochemical staining of primary RMS tumor sections confirmed high levels of ER beta but not ER alpha protein.
  • [MeSH-minor] Apoptosis / drug effects. Estradiol / pharmacology. Estrogen Antagonists / pharmacology. Estrogen Receptor alpha / genetics. Estrogen Receptor alpha / metabolism. Estrogen Receptor alpha / physiology. Gene Expression Regulation, Neoplastic. Humans. Signal Transduction / drug effects. Tissue Distribution. Tumor Cells, Cultured. Tumor Stem Cell Assay


Advertisement
4. Shi B, Zhu Y, Xu Z, Liu Y, Zheng B, Qi T: Aggressive fibromatosis in the urological system. Report of two adult patients and review of the literature. Urol Int; 2007;78(1):93-6
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Aggressive fibromatosis in the urological system. Report of two adult patients and review of the literature.
  • Aggressive fibromatoses (AF) are locally aggressive neoplasms that do not metastasize but are frequently associated with one or more recurrences and subsequent associated morbidity.
  • AF in the urological system is quite rare and has mainly been described in single case reports or as isolated cases in a large series of extra-abdominal desmoid tumors.
  • [MeSH-major] Fibromatosis, Aggressive / diagnosis. Genital Neoplasms, Male / diagnosis. Scrotum. Urinary Bladder Neoplasms / diagnosis
  • [MeSH-minor] Adult. Cystoscopy. Diagnosis, Differential. Follow-Up Studies. Humans. Male. Tomography, X-Ray Computed. Urography. Urologic Surgical Procedures, Male / methods


5. Ioannou M, Demertzis N, Iakovidou I, Kottakis S: The role of imatinib mesylate in adjuvant therapy of extra-abdominal desmoid tumors. Anticancer Res; 2007 Mar-Apr;27(2):1143-7
Hazardous Substances Data Bank. IMATINIB MESYLATE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The role of imatinib mesylate in adjuvant therapy of extra-abdominal desmoid tumors.
  • BACKGROUND: Extra-abdominal desmoid tumors are rare neoplasms with variable biological behavior.
  • The purpose of this study was to determine the possible presence of tyrosine-kinase receptors in extra-abdominal desmoid tumors as a marker for imatinib mesylate therapy.
  • PATIENTS AND METHODS: From 1999 to 2004, immunohistochemical methods were carried-out in 14 patients with histologically confirmed extra-abdominal desmoid tumors to determine c-KIT positivity (existence of tyrosine-kinase receptors and PDGFRA and PDGFRB).
  • RESULTS: All desmoid tumors were c-KIT negative, which demonstrates absence of tyrosine-kinase receptors.
  • CONCLUSION: The histological c-KIT markup is an easy and reliable method that can detect whether a desmoid tumor is sensitive to additional treatment with a tyrosine-kinase receptor inhibitor.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Fibromatosis, Aggressive / drug therapy. Piperazines / therapeutic use. Pyrimidines / therapeutic use

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17465254.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Benzamides; 0 / Piperazines; 0 / Pyrimidines; 8A1O1M485B / Imatinib Mesylate; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit; EC 2.7.10.1 / Receptor, Platelet-Derived Growth Factor alpha; EC 2.7.10.1 / Receptor, Platelet-Derived Growth Factor beta
  •  go-up   go-down


6. Wilhelm A, Jolles HI, Krishna M: Anterior mediastinal desmoid tumor with CT and MR imaging. J Thorac Imaging; 2007 Aug;22(3):252-5
Genetic Alliance. consumer health - Desmoid Tumor.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Anterior mediastinal desmoid tumor with CT and MR imaging.
  • Desmoid tumors, or aggressive fibromatoses, are rare, histologically benign tumors with biologic behavior that is intermediate between benign fibrous proliferations and low-grade fibrosarcoma.
  • These tumors can cause significant morbidity and mortality by their propensity for local invasion and recurrence following surgical excision.
  • A case of an anterior mediastinal desmoid tumor in a 67-year-old woman is reported with computed tomography and magnetic resonance imaging findings.
  • [MeSH-major] Fibromatosis, Aggressive / diagnosis. Mediastinal Neoplasms / diagnosis
  • [MeSH-minor] Aged. Contrast Media. Diagnosis, Differential. Female. Humans. Magnetic Resonance Imaging. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17721335.001).
  • [ISSN] 0883-5993
  • [Journal-full-title] Journal of thoracic imaging
  • [ISO-abbreviation] J Thorac Imaging
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


7. Zhang ZL, Liang CH, Liu YB, Xie SF, Yu YX, Wang QS, Liu ZY, Li JL: [Computed tomography and magnetic resonance imaging features of desmoid-type fibromatosis: comparison with the pathological findings]. Nan Fang Yi Ke Da Xue Xue Bao; 2010 Nov;30(11):2495-7
Genetic Alliance. consumer health - Fibromatosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Computed tomography and magnetic resonance imaging features of desmoid-type fibromatosis: comparison with the pathological findings].
  • OBJECTIVE: To explore the computed tomography (CT) and magnetic resonance imaging (MRI) features of desmoid-type fibromatosis, and improve the diagnostic accuracy and understanding of the disease.
  • METHODS: The CT and MRI features of 18 cases of surgically and pathologically confirmed desmoid-type fibromatosis were reviewed retrospectively.
  • RESULTS: In the extra abdominal cases, the tumors occurred in the head and neck in 3, in the dorsal part of the chest in 2, in the abdominal wall and groin area in 9, and in the peritoneal cavity in 4; concomitant Gardner syndrome was found in 1 case.
  • In 4 cases the tumor occurred within 1 to 3 years after abdominal surgeries.
  • On CT and MRI, the lesion appeared benign with malignant growth pattern, and caused compression of the adjacent organs and vessels or encasement of the vessels; the border was unclear without encapsulation, and necrosis and calcification was scarce.
  • The density and signal of the tumor were well distributed.
  • CONCLUSION: The CT and MRI features of desmoid-type fibromatosis are characteristic, and CT and MRI are valuable modalities for the diagnosis and differential diagnosis of the tumor.
  • [MeSH-major] Fibromatosis, Aggressive / pathology. Fibromatosis, Aggressive / radiography

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21097415.001).
  • [ISSN] 1673-4254
  • [Journal-full-title] Nan fang yi ke da xue xue bao = Journal of Southern Medical University
  • [ISO-abbreviation] Nan Fang Yi Ke Da Xue Xue Bao
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] China
  •  go-up   go-down


8. Eren S: A sporadic abdominal desmoid tumour case presenting with intermittent intestinal obstruction. Eur J Pediatr Surg; 2005 Jun;15(3):196-9
MedlinePlus Health Information. consumer health - Intestinal Obstruction.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A sporadic abdominal desmoid tumour case presenting with intermittent intestinal obstruction.
  • Desmoid tumours, also known as aggressive fibromatoses, are rare lesions having intermediate biological behaviour between benign fibrous lesions and fibrosarcomas.
  • Although abdominal desmoids have an increased incidence in Gardner's syndrome, they are rarely found in isolated form.
  • Although intraabdominal desmoids are usually detected as a solitary lesion in sporadic cases, the case presented here had two mesenteric lesions in the left upper quadrant.
  • [MeSH-major] Fibromatosis, Aggressive / diagnosis. Intestinal Obstruction / complications. Mesentery. Peritoneal Neoplasms / diagnosis
  • [MeSH-minor] Child. Colon / pathology. Humans. Male. Nausea / etiology. Neoplasm Invasiveness. Vomiting / etiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15999314.001).
  • [ISSN] 0939-7248
  • [Journal-full-title] European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift für Kinderchirurgie
  • [ISO-abbreviation] Eur J Pediatr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


9. Ferenc T, Stalińska L, Turant M, Sygut J, Tosik D, Dziki A, Kulig A: Analysis of TGF-beta protein expression in aggressive fibromatosis (desmoid tumor). Pol J Pathol; 2006;57(2):77-81
Genetic Alliance. consumer health - Fibromatosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Analysis of TGF-beta protein expression in aggressive fibromatosis (desmoid tumor).
  • Aggressive fibromatosis, usually termed desmoid tumor, develops from muscle connective tissue, fasciae and aponeuroses.
  • Aggressive fibromatosis located in various parts of the body demonstrates differentiated biological behavior.
  • Abnormalities in TGF-beta expression are very common in many disease processes, including neoplasms.
  • Immunohistochemical analysis employing a monoclonal antibody against TGF-beta was performed on archival material, consisting of 38 cases of aggressive fibromatosis, among which 23 represented abdominal, 11 extra-abdominal and 4 intra-abdominal localizations.
  • The average percentage of cells positively stained for TGF-beta protein was 40.2% in the group of extra-abdominal, 58.5% in the group of abdominal and 72.8% in the group of intra-abdominal localizations.
  • There were significant differences observed between the analyzed groups of desmoid tumor (p<0.05).
  • A positive cytoplasmic reaction for TGF-beta was noted in 65.8% (25/38) of the aggressive fibromatoses.
  • Overexpression of TGF-beta protein was noted in 39.5% (15/38) of the aggressive fibromatoses.
  • High expression noticed in desmoid fibroblasts might indicate that this protein plays a crucial role in the development of aggressive fibromatosis.
  • [MeSH-major] Abdominal Neoplasms / metabolism. Fibromatosis, Aggressive / metabolism. Transforming Growth Factor beta / metabolism
  • [MeSH-minor] Biomarkers, Tumor / metabolism. Cell Count. Cytoplasm / metabolism. Cytoplasm / pathology. Fibroblasts / metabolism. Fibroblasts / pathology. Humans. Image Processing, Computer-Assisted. Immunoenzyme Techniques

  • Genetic Alliance. consumer health - Desmoid Tumor.
  • Genetic Alliance. consumer health - Aggressive Fibromatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17019969.001).
  • [ISSN] 1233-9687
  • [Journal-full-title] Polish journal of pathology : official journal of the Polish Society of Pathologists
  • [ISO-abbreviation] Pol J Pathol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Poland
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Transforming Growth Factor beta
  •  go-up   go-down


10. Janitzky A, Porsch M, Daher M, Küster D, Liehr UB: [Aggressive fibromatosis (desmoid tumor) : A rare differential diagnosis of metastasis of renal cell carcinoma]. Urologe A; 2010 Jan;49(1):81-3
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Aggressive fibromatosis (desmoid tumor) : A rare differential diagnosis of metastasis of renal cell carcinoma].
  • [Transliterated title] Aggressive Fibromatose (Desmoidfibromatose) : Seltene Differentialdiagnose einer Nierenzellkarzinommetastase.
  • We report the case of a 65-year-old woman with an aggressive fibromatosis of the rectus abdominis muscle suspicious for a metastasis of renal cell carcinoma after tumor nephrectomy 3 years previously.
  • Aggressive fibromatoses (desmoid tumors) are rare semimalignant tumors of the connective tissue with local infiltration and destruction of tissue.
  • Complete resection is essential to avoid tumor relapse.
  • Aggressive fibromatosis must be considered in the differential diagnosis of renal cell carcinoma metastasis.
  • [MeSH-major] Abdominal Muscles / pathology. Carcinoma, Renal Cell / diagnosis. Carcinoma, Renal Cell / secondary. Fibromatosis, Abdominal / diagnosis. Kidney Neoplasms / diagnosis. Muscle Neoplasms / pathology
  • [MeSH-minor] Aged. Diagnosis, Differential. Female. Humans


11. Motsch C, Schmitt J, Roessner A, Mittler U, Freigang B: [Desmoid tumors of the head and neck]. Laryngorhinootologie; 2007 Jul;86(7):524-7
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Desmoid tumors of the head and neck].
  • Desmoid tumors of the head and neck, also known as aggressive fibromatoses, are rare.
  • They are soft tissue neoplasms arising from musculoaponeurotic structures and characterized of locally aggressive infiltration and recurrences.
  • Complete surgical excision of desmoid tumors is considered to be the only effective method of cure.
  • MRI is the first choice in the preoperative evaluation of neck desmoids.
  • We describe the successful treatment of desmoid tumors in two cases (M. sternocleidomastoideus, M. levator scapulae).
  • [MeSH-major] Fibromatosis, Aggressive / diagnosis. Head and Neck Neoplasms / diagnosis. Muscle Neoplasms / diagnosis. Neck Muscles
  • [MeSH-minor] Biopsy. Chemotherapy, Adjuvant. Child. Combined Modality Therapy. Cranial Nerve Injuries / diagnosis. Cranial Nerve Injuries / prevention & control. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Monitoring, Intraoperative. Neck Dissection. Neoplasm, Residual / diagnosis. Neoplasm, Residual / drug therapy. Neoplasm, Residual / radiotherapy. Neoplasm, Residual / surgery. Postoperative Complications / diagnosis. Postoperative Complications / prevention & control. Radiotherapy, Adjuvant. Reoperation

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17219337.001).
  • [ISSN] 0935-8943
  • [Journal-full-title] Laryngo- rhino- otologie
  • [ISO-abbreviation] Laryngorhinootologie
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


12. Kuhnen C, Helwing M, Rabstein S, Homann HH, Müller KM: [Desmoid-type fibromatosis (aggressive fibromatosis)]. Pathologe; 2005 Mar;26(2):117-26
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Desmoid-type fibromatosis (aggressive fibromatosis)].
  • [Transliterated title] Desmoidfibromatosen (aggressive Fibromatosen) Klinisch-pathologische Korrelationen und Differenzialdiagnose spindelzelliger fibroblastisch/myofibroblastischer Tumoren des Weichgewebes.
  • Desmoid-type fibromatoses (aggressive fibromatoses) represent infiltrative, locally destructively growing soft tissue tumors with a high potential for recurrence.
  • Desmoid tumors of 33 adult patients were analysed regarding clinical and morphological aspects (sex, age distribution, site, size, mitotic rate, tumor microvessel density, surgical margins, additional radiotherapy).
  • No prognostic significance of tumor microvessel density was evident.
  • The presented results may indicate an increased risk for local relapse in those desmoid-type fibromatoses which are mitotically active.
  • Postoperative radiotherapy seems to be effective in the treatment of aggressive fibromatosis to avoid tumor recurrence.
  • Differential diagnosis of desmoid-type fibromatosis/aggressive fibromatosis in adulthood include various fibroblastic/myofibroblastic soft tissue tumors such as nodular fasciitis, fibrosarcoma, low-grade fibromyxoid sarcoma, myofibroblastic sarcoma as well as leiomyosarcoma and soft tissue leiomyoma.
  • [MeSH-major] Fibromatosis, Aggressive / pathology

  • Genetic Alliance. consumer health - Aggressive Fibromatosis.
  • Genetic Alliance. consumer health - Fibromatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15657684.001).
  • [ISSN] 0172-8113
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


13. Tanaka H, Harasawa A, Furui S: Usefulness of MR imaging in assessment of tumor extent of aggressive fibromatosis. Radiat Med; 2005 Mar;23(2):111-5
Hazardous Substances Data Bank. GADOPENTETATE DIMEGLUMINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Usefulness of MR imaging in assessment of tumor extent of aggressive fibromatosis.
  • PURPOSE: We evaluated the usefulness of MR imaging for aggressive fibromatoses in order to determine tumor extent.
  • RESULTS: The tumor had a smooth margin in 41% of cases, while an irregular margin was present in 59%.
  • CONCLUSION: Detection of LSBs on MR images is important for the determination of tumor extent, which allows the surgical method to be decided and postoperative recurrence predicted.
  • [MeSH-major] Fibromatosis, Aggressive / diagnosis. Magnetic Resonance Imaging
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Contrast Media. Fascia / pathology. Female. Follow-Up Studies. Gadolinium DTPA. Humans. Image Enhancement / methods. Male. Middle Aged. Neoplasm Invasiveness. Retrospective Studies. Soft Tissue Neoplasms / diagnosis. Tendons / pathology

  • Genetic Alliance. consumer health - Aggressive Fibromatosis.
  • Genetic Alliance. consumer health - Fibromatosis.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15827528.001).
  • [ISSN] 0288-2043
  • [Journal-full-title] Radiation medicine
  • [ISO-abbreviation] Radiat Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Contrast Media; 84F6U3J2R6 / gadodiamide; K2I13DR72L / Gadolinium DTPA
  •  go-up   go-down


14. Bowley E, O'Gorman DB, Gan BS: Beta-catenin signaling in fibroproliferative disease. J Surg Res; 2007 Mar;138(1):141-50
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Beta-catenin signaling in fibroproliferative disease.
  • MATERIALS AND METHODS: Cellular accumulation of beta-catenin levels can result in transactivation of gene transcription and cellular proliferation during normal cellular and disease development.
  • RESULTS: This finding is in keeping with previous observations that post-translational modifications of beta-catenin that are associated with its cytoplasmic accumulation are frequently observed in fibroproliferative diseases with characteristics of dysregulated wound healing.
  • These diseases include hypertrophic scar formation, aggressive fibromatoses, Lederhose disease, and Dupuytren's contracture (DC).
  • CONCLUSIONS: While its precise roles in disease initiation and progression remain to be explored, this review highlights our current knowledge of beta-catenin regulation and describes some potential upstream mediators of beta-catenin accumulation and signaling in fibroproliferative disease.
  • [MeSH-minor] Animals. Fibroma / metabolism. Fibroma / pathology. Fibrosis. Humans. Skin Neoplasms / metabolism. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Scars.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17109886.001).
  • [ISSN] 0022-4804
  • [Journal-full-title] The Journal of surgical research
  • [ISO-abbreviation] J. Surg. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / beta Catenin
  • [Number-of-references] 113
  •  go-up   go-down


15. Camargo VP, Maki RG: Clinical outcomes of systemic therapy for patients with desmoids. J Clin Oncol; 2009 May 20;27(15_suppl):10585

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinical outcomes of systemic therapy for patients with desmoids.
  • : 10585 Background: Desmoids are rare, slow growing, histologically benign tumors without metastatic potential.
  • METHODS: We examined outcomes of patients with desmoid tumors receiving systemic therapy at a single institution, to provide a basis for examination of newer agents.
  • Retrospective chart review of 682 patients with desmoid tumors (1982-2006) from a prospectively collected sarcoma database.
  • Patients without measurable disease, those receiving therapy we could not document, and those receiving prophylactic therapy were excluded.
  • Nine patients died, 7 of progressive disease/surgical complications, and two with Gardner syndrome-related malignancies.
  • Intra-abdominal primary location was most common (29/70=41%).
  • CONCLUSIONS: Anthracycline-containing regimens, hormonal therapy, and tyrosine kinase inhibitors have modest activity against desmoid tumors.
  • The choice of therapy for these morbid and potentially fatal tumors should balance the efficacy of treatments with their short- and long-term side effects.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963883.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


16. Dufresne A, Penel N, Salas S, Le Cesne A, Perol D, Bui B, Brain E, Ray-Coquard I, Jimenez M, Blay J: Updated outcome with long-term follow-up of imatinib for the treatment of progressive or recurrent aggressive fibromatosis (desmoid tumor): A FNCLCC/ French Sarcoma Group phase II trial. J Clin Oncol; 2009 May 20;27(15_suppl):10518

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Updated outcome with long-term follow-up of imatinib for the treatment of progressive or recurrent aggressive fibromatosis (desmoid tumor): A FNCLCC/ French Sarcoma Group phase II trial.
  • : 10518 Background: We present updated results from a previously reported phase II trial assessing clinical efficacy of imatinib in progressive or recurrent aggressive fibromatosis (Fayette et al.
  • ASCO 2007) Methods: Patients with aggressive fibromatosis not amenable to radiotherapy or non-mutilating surgery were eligible and received imatinib 400mg daily (increased to 800mg daily in case of progression) up to 1 year then stopped.
  • The primary end point was non-progressive disease rate at 3 months.
  • Two patients with mesenteric aggressive fibromatosis died from progressive disease.
  • CONCLUSIONS: With a 2.8 years median follow up, this is the largest study which confirms the high efficacy of imatinib (400 mg daily) in patients presenting with aggressive fibromatosis failing local treatment and with documented evidence of progressive disease before imatinib treatment.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963656.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. Constantinidou A, Scurr M, Jones R, Al-Muderis O, Judson I: Treatment of aggressive fibromatosis with pegylated liposomal doxorubicin: The Royal Marsden Hospital experience. J Clin Oncol; 2009 May 20;27(15_suppl):10519

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Treatment of aggressive fibromatosis with pegylated liposomal doxorubicin: The Royal Marsden Hospital experience.
  • : 10519 Background: Aggressive fibromatosis (AF) or desmoid tumors are monoclonal proliferations which are locally invasive but do not metastasise.
  • Sporadic tumors are usually associated with mutations in the beta-catenin gene CTNNB1whereas those occurring in the context of familial adenomatous polyposis usually have inactivating mutations in APC.
  • When surgery and radiotherapy are not applicable or fail to control the disease, systemic treatment with anti-oestrogens, non steroidal anti-inflammatory drugs (NSAIDs) and chemotherapy can be used.
  • All patients had progressive fibromatosis.
  • Objective response according to RECIST was achieved in 4/10 patients and in 5 patients the best response was stable disease.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963658.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


18. Indelicato DJ, Keole SR, Shahlaee AH, Morris CG, Gibbs CP, Scarborough MT, Islam S, Marcus RB: Ewing tumors of the chest wall: Local control and long-term outcomes. J Clin Oncol; 2009 May 20;27(15_suppl):e21501

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ewing tumors of the chest wall: Local control and long-term outcomes.
  • Pts characteristics: median age 41 (19-80 y), male/female 19/12; symptoms at diagnosis: dyspnoea (42%), chest and shoulder pain (39%), cough (35%), hemophtoae (13%), discomfort (10%).
  • 5 mediastinal tumours were located as follows: 2 in anterior part, 1 in posterior and 2 in the middle (sarcomas of the heart).
  • 26 lung sarcomas presented as a singular mass in 23 cases and as a metastatic disease in 3.
  • RESULTS: In 20/31 cases the tumour was immediately resected (3 mediastinal masses and 17 lung sarcomas).
  • The histology were: peripheral nerve tumour 7, leiomyosarcoma 4, MFH 2, fibrosarcoma 2, liposarcoma 1, angiosarcoma 2, undifferentiated sarcoma 1, solitary fibrous tumour 2, rhabdomyosarcoma 2, synovialsarcoma 2, pulmonary artery sarcoma 1, pleuropolmonary blastoma 1, malignant hemangiopericytoma 1, mixoid chondrosarcoma 1, ectopic osteosarcoma 1, aggressive fibromatosis 1.
  • Only 4 pts received neoadjuvant chemotherapy, 11 adjuvant CT, 5 exclusive CT + RT for inoperable disease.
  • Of these only 8 are alive (2 with disease).
  • Volume of disease, complete resection and grading are the dominant prognostic factors.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963390.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


19. Comandone A, Boglione A, Pochettino P, Berno E, Inguì M, Papotti M, Borasio P, Maggi G, Brach Del Prever E, Gino G: Primary sarcomas of the lungs and mediastinum: Clinicopathological study and therapy results of Piedmontese Group for Sarcomas. J Clin Oncol; 2009 May 20;27(15_suppl):e21509

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pts characteristics: median age 41 (19-80 y), male/female 19/12; symptoms at diagnosis: dyspnoea (42%), chest and shoulder pain (39%), cough (35%), hemophtoae (13%), discomfort (10%).
  • 5 mediastinal tumours were located as follows: 2 in anterior part, 1 in posterior and 2 in the middle (sarcomas of the heart).
  • 26 lung sarcomas presented as a singular mass in 23 cases and as a metastatic disease in 3.
  • RESULTS: In 20/31 cases the tumour was immediately resected (3 mediastinal masses and 17 lung sarcomas).
  • The histology were: peripheral nerve tumour 7, leiomyosarcoma 4, MFH 2, fibrosarcoma 2, liposarcoma 1, angiosarcoma 2, undifferentiated sarcoma 1, solitary fibrous tumour 2, rhabdomyosarcoma 2, synovialsarcoma 2, pulmonary artery sarcoma 1, pleuropolmonary blastoma 1, malignant hemangiopericytoma 1, mixoid chondrosarcoma 1, ectopic osteosarcoma 1, aggressive fibromatosis 1.
  • Only 4 pts received neoadjuvant chemotherapy, 11 adjuvant CT, 5 exclusive CT + RT for inoperable disease.
  • Of these only 8 are alive (2 with disease).
  • Volume of disease, complete resection and grading are the dominant prognostic factors.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963441.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


20. Dumont AG, Lev D, Lazar A, Joensuu H, Trent J: Simultaneous gastrointestinal stromal tumor (GIST) and desmoid fibromatosis (DF). J Clin Oncol; 2009 May 20;27(15_suppl):10568

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Simultaneous gastrointestinal stromal tumor (GIST) and desmoid fibromatosis (DF).
  • : 10568 Background: Desmoid Fibromatosis (DF) is one of a group of rare fibrous tissue proliferations (2-4 cases per year per million) which tend to be locally aggressive but have no propensity for metastasis.
  • Gastrointestinal Stromal Tumor (GIST) is the most common mesenchymal tumors of the gastrointestinal tract and also rare (15-20 cases per year per million).
  • In 5 cases, the GIST was diagnosed prior to the DF while one case had both tumors synchronous at presentation.
  • The 3 others were intra-abdominal DF.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27963790.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


21. Ferenc T, Sygut J, Kopczyński J, Mayer M, Latos-Bieleńska A, Dziki A, Kulig A: Aggressive fibromatosis (desmoid tumors): definition, occurrence, pathology, diagnostic problems, clinical behavior, genetic background. Pol J Pathol; 2006;57(1):5-15
Genetic Alliance. consumer health - Fibromatosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Aggressive fibromatosis (desmoid tumors): definition, occurrence, pathology, diagnostic problems, clinical behavior, genetic background.
  • Aggressive fibromatosis, usually called desmoid tumor develops from muscle connective tissue, fasciae and aponeuroses.
  • This neoplasm is composed of spindle (fibrocyte-like) cells.
  • As regards the site, aggressive fibromatoses can be divided into: extra-abdominal in the area of the shoulder and pelvic girdle or chest and neck wall; abdominal in abdominal wall muscles; intra-abdominal concerning pelvis, mesentery connective tissue or retroperitoneal space.
  • Desmoid tumor is a neoplasm which rarely turns malignant and is non-metastasizing but demonstrates ability to local infiltration into tissue and is characterized by high risk of recurrence (25-65%) after surgical treatment.
  • Desmoid tumor etiology is uncertain.
  • This neoplasm occurs in sporadic (idiopathic) form and is also associated with some familial neoplastic syndromes.
  • Most sporadic cases of aggressive fibromatosis contain a somatic mutation in either the adenomatous polyposis coli (APC) or beta-catenin genes.
  • Sporadic tumors are more frequent in women than in men from 2 : 1 to 5 : 1.
  • In about 10-15 per cent of patients with familial adenomatous polyposis (FAP), aggressive fibromatosis is a parenteral manifestation of this familial syndrome conditioned by APC gene mutation.
  • Abdomen injury--most frequently due to surgery is said to play an important role in the initiation of fibrous tissue proliferative process in the cases of abdominal and intra abdominal forms.
  • High cells growth potential with relatively high local malignancy is observed in about 10% of cases with sporadic tumors as well as in those FAP-associated.
  • [MeSH-major] Fibromatosis, Aggressive. Mesoderm / pathology

  • Genetic Alliance. consumer health - Aggressive Fibromatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16739877.001).
  • [ISSN] 1233-9687
  • [Journal-full-title] Polish journal of pathology : official journal of the Polish Society of Pathologists
  • [ISO-abbreviation] Pol J Pathol
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] Poland
  • [Number-of-references] 93
  •  go-up   go-down


22. Tolan S, Shanks JH, Loh MY, Taylor B, Wylie JP: Fibromatosis: benign by name but not necessarily by nature. Clin Oncol (R Coll Radiol); 2007 Jun;19(5):319-26
Genetic Alliance. consumer health - Fibromatosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fibromatosis: benign by name but not necessarily by nature.
  • Aggressive fibromatoses, also known as desmoid tumours, are rare fibrous tissue proliferations with a tendency for slow, local infiltrative growth.
  • Magnetic resonance imaging is the method of choice for diagnosis, pre-treatment planning and post-treatment follow-up.
  • Radiotherapy is used to reduce local recurrence rates after excision and is also used to treat inoperable tumours.
  • Treatment is now planned using modern three-dimensional conformal techniques, similar to those used in soft tissue sarcoma management.
  • There are no randomised trials to help guide the management of this locally aggressive 'benign' tumour and treatment decisions are best made by the local soft tissue sarcoma multidisciplinary team.
  • [MeSH-major] Fibromatosis, Aggressive / diagnosis. Fibromatosis, Aggressive / therapy
  • [MeSH-minor] Diagnosis, Differential. Dose Fractionation. Humans. Magnetic Resonance Imaging. Radiotherapy / methods. Radiotherapy Dosage

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17419039.001).
  • [ISSN] 0936-6555
  • [Journal-full-title] Clinical oncology (Royal College of Radiologists (Great Britain))
  • [ISO-abbreviation] Clin Oncol (R Coll Radiol)
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 35
  •  go-up   go-down


23. Chung KH, Charlton A, Arbuckle S, Chaseling R, Owler BK: Metachronous multifocal desmoid-type fibromatoses along the neuraxis with adenomatous polyposis syndrome. J Neurosurg Pediatr; 2010 Oct;6(4):372-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metachronous multifocal desmoid-type fibromatoses along the neuraxis with adenomatous polyposis syndrome.
  • Desmoid-type fibromatosis, aggressive fibromatosis, or desmoid tumor is an uncommon benign but locally aggressive fibroblastic lesion.
  • Although intraabdominal desmoid-type fibromatoses are well described in association with adenomatous polyposis syndrome, their occurrence along the neuraxis is extremely rare.
  • The authors report the case of a 14-year-old boy with metachronous intracranial and spinal desmoid-type fibromatoses with preceding medulloblastoma.
  • This is the first reported case of spinal desmoid-type fibromatosis in association with adenomatous polyposis syndrome.
  • The identification of an underlying genetic instability allows for screening to detect lesions and institute measures to avoid preventable mortality from nonneurological tumors.
  • [MeSH-major] Adenomatous Polyposis Coli / pathology. Cerebral Ventricle Neoplasms / pathology. Fibromatosis, Aggressive / pathology. Genes, APC. Neoplasms, Multiple Primary / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20887112.001).
  • [ISSN] 1933-0715
  • [Journal-full-title] Journal of neurosurgery. Pediatrics
  • [ISO-abbreviation] J Neurosurg Pediatr
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


24. Yang JL, Wang J, Zhou XY, Li XQ, Hou YY, Zhu XZ: [Clinicopathologic and genetic studies of desmoid-type fibromatosis]. Zhonghua Bing Li Xue Za Zhi; 2006 Mar;35(3):145-50
Genetic Alliance. consumer health - Fibromatosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinicopathologic and genetic studies of desmoid-type fibromatosis].
  • OBJECTIVE: To study the clinicopathological and genetic features of desmoid-type fibromatosis, and to investigate the feasibility of detecting trisomy 8 in formalin fixed, paraffin embedded (FFPE) tissue by fluorescence in-situ hybridization (FISH).
  • Histopathologic and immunohistochemical evaluations were available in 69 cases, and ultrastructural evaluation was done in 2 cases of desmoid-type fibromatosis.
  • FFPE tissue sections were available in 20 tumors for the trisomy 8 detection by FISH.
  • Clinically, there were 44 extra-abdominal tumors, 28 abdominal wall tumors and 23 intra-abdominal lesions mostly involving the mesentery.
  • Histologically, desmoid-type fibromatoses showed longitudinal fascicles of spindle fibroblasts and myofibroblasts in a predominantly collagenous background.
  • The tumor cells stained positive for vimentin, alpha-smooth muscle actin, desmin, and beta-catenin (47.8%, 33/69).
  • Ultrastructurally, most tumor cells had features of fibroblasts, including rich endoplasmic reticulum and Golgi apparatus.
  • Some tumor cells were myofibroblast-like cells exhibiting intercellular junctions, fibronexous junctions and stress fibers.
  • Trisomy 8 was detected in 6 of 20 cases of desmoid-type fibromatosis including 5 of the 8 recurrent tumors but only one of the 12 primary tumors.
  • The latter tumor also recurred three years later.
  • CONCLUSIONS: Desmoid-type fibromatosis is an intermediate (locally aggressive) tumor that occurs predominantly in young females.
  • Trisomy 8 can be detected in FFPE tissue by FISH, and its presence serves as a useful predictor of tumor recurrence and may define a subtype of desmoid-type fibromatosis with high recurrence rate.
  • [MeSH-major] Fibromatosis, Abdominal / pathology. Fibromatosis, Aggressive / pathology. Peritoneal Neoplasms / pathology. Trisomy
  • [MeSH-minor] Actins / analysis. Adult. Aged. Aged, 80 and over. Child. Chromosomes, Human, Pair 8 / genetics. Desmin / analysis. Feasibility Studies. Female. Humans. Immunohistochemistry. In Situ Hybridization, Fluorescence. Male. Mesentery. Middle Aged. Muscle, Smooth / chemistry. Neoplasm Recurrence, Local. Vimentin / metabolism. beta Catenin / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16630502.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Actins; 0 / Desmin; 0 / Vimentin; 0 / beta Catenin
  •  go-up   go-down


25. Nakayama T, Tsuboyama T, Toguchida J, Hosaka T, Nakamura T: Natural course of desmoid-type fibromatosis. J Orthop Sci; 2008 Jan;13(1):51-5
Genetic Alliance. consumer health - Fibromatosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Natural course of desmoid-type fibromatosis.
  • BACKGROUND: Desmoid-type fibromatosis is a locally aggressive tumor known to have high potential for local recurrence after resection, while it exhibits self-limiting behavior and shows growth arrest or spontaneous regression in many patients.
  • METHODS: We retrospectively reviewed clinical outcome and changes in tumor size in 11 consecutive patients with extremity and trunk desmoid-type fibromatoses, who were basically observed without any treatment after diagnosis.
  • RESULTS: For two patients in whom the tumors were initially incorrectly diagnosed as other tumors, surgical resection was performed.
  • For another two patients, surgical resections were performed in the follow-up periods due to tumor enlargement or joint contracture.
  • In all four patients who underwent surgery, tumors recurred shortly after resection and re-resection was not performed.
  • During the follow-up periods with a median length of 56 months, ten tumors eventually stopped growing, and three of them regressed spontaneously.
  • At the time of final follow-up, ten patients were alive with residual disease without severe morbidity.
  • In one patient, the tumor enlarged to over 30 cm in diameter with a substantial functional deficit.
  • CONCLUSIONS: Simple observation is a noninvasive and function-preserving treatment for desmoid-type fibromatosis.
  • [MeSH-major] Fibromatosis, Aggressive / pathology
  • [MeSH-minor] Adolescent. Adult. Cohort Studies. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Regression, Spontaneous. Outcome and Process Assessment (Health Care). Retrospective Studies. Tomography, X-Ray Computed. Tumor Burden

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18274856.001).
  • [ISSN] 0949-2658
  • [Journal-full-title] Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association
  • [ISO-abbreviation] J Orthop Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


26. Zhang HY, Ke Q, Zhang Z, Zhang R, Fu J, Chen HJ, Wei B, Bu H: [Expression of beta-catenin and estrogen receptor in desmoid-type fibromatosis]. Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan;41(1):101-5
Genetic Alliance. consumer health - Fibromatosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Expression of beta-catenin and estrogen receptor in desmoid-type fibromatosis].
  • OBJECTIVE: To detect the expression of beta-catenin and Estrogen Receptor in desmoid-type fibromatosis.
  • METHODS: Nuclear beta-catenin expression was detected by immunohistochemistry in 77 lesions with desmoid-type fibromatosis and 171 other spindle cell lesions, including superficial fibromatosis (n = 18), nodular fasciitis (n = 36), keloid (n = 16), scar (n = 10), granulation tissue (n = 9), synovial sarcoma (n = 38), neufibroma (n = 13), solitary fibrous tumor (n =12), gastrointestinal stromal tumor (n = 10), low-grade myxofibrosarcoma (n = 3), low-grade fibromyxoid sarcoma (n = 3), and smooth muscle tumor (n = 10).
  • In addition, the immunohistochemical expressions of ER-alpha, ER-beta and Ki-67 were examined in all of the lesions with desmoid-type fibromatosis.
  • RESULTS: High-level nuclear beta-catenin staining was detected in a very limited subset of tissue types, which included 70.1% of lesions with desmoid-type fibromatosis (54/77) and 6.3% of lesions with keloid (1/16).
  • None of the lesions with desmoid-type fibromatosis expressed ER-alpha.
  • However, 62 (80.5%) of the lesions with desmoids-type fibromatosis were positive in ER-beta, which included 52 (67.5%) with high-level expression, and 10 (13%) with low-level expression.
  • The lesions with desmoid-type fibromatosis had very low Ki-67 positive rate.
  • The recurrence of desmoids-type fibromatosis was not correlated independently with beta-catenin, ER-beta or Ki-67.
  • CONCLUSION: High-level nuclear beta-catenin staining serves as a useful diagnostic tool for desmoid-type fibromatosis.
  • The high expression of ER-beta in desmoid-type fibromatosis provides a biological mechanism for the antiestrogenic compounds to treat fibromatosis.
  • Beta-catenin, ER-beta or Ki-67 can not predict the prognosis of desmoid-type fibromatosis.
  • [MeSH-major] Fibroma / metabolism. Receptors, Estrogen / metabolism. Soft Tissue Neoplasms / metabolism. beta Catenin / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20369480.001).
  • [ISSN] 1672-173X
  • [Journal-full-title] Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
  • [ISO-abbreviation] Sichuan Da Xue Xue Bao Yi Xue Ban
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Receptors, Estrogen; 0 / beta Catenin
  •  go-up   go-down


27. Zampieri N, Cecchetto M, Zorzi MG, Pietrobelli A, Ottolenghi A, Camoglio F: An unusual case of extra-abdominal desmoid tumour. Eur J Cancer Care (Engl); 2010 May;19(3):410-2

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An unusual case of extra-abdominal desmoid tumour.
  • Desmoid tumour is relatively rare and generally non-metastatisizing lesion of mesenchymal origin composed of fibrous tissue and fitting in the group of aggressive fibromatosis; it is a locally aggressive proliferative soft-tissue lesion with controversial nature.
  • This tumour accounts for 0.03% of all tumours and 3% of soft-tissue tumours with annual incidence of two to four cases per million.
  • Although desmoid tumours are more common in persons aged 10-40 years than in others, they do occur in young children and older adults; in children the sex incidence is equal.
  • This is a rare case of extra-abdominal desmoid tumour in a 14-year-old girl affected by spastic tetraparesis.
  • [MeSH-major] Fibromatosis, Aggressive / diagnosis. Soft Tissue Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19709174.001).
  • [ISSN] 1365-2354
  • [Journal-full-title] European journal of cancer care
  • [ISO-abbreviation] Eur J Cancer Care (Engl)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


28. Huang PW, Tzen CY: Prognostic factors in desmoid-type fibromatosis: a clinicopathological and immunohistochemical analysis of 46 cases. Pathology; 2010 Feb;42(2):147-50
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognostic factors in desmoid-type fibromatosis: a clinicopathological and immunohistochemical analysis of 46 cases.
  • AIMS: To determine risk factors for recurrence of desmoid-type fibromatosis (aggressive fibromatosis).
  • METHODS: Forty-six cases of desmoid-type fibromatosis in Taiwanese patients were analysed for an association between tumour recurrence and clinical features, pathology, and the presence of p53 protein and beta-catenin on immunohistochemical staining.
  • The only factor significantly associated with tumour recurrence was positive surgical margin (p = 0.035).
  • CONCLUSIONS: A positive surgical margin is a risk factor for recurrence of desmoid-type fibromatosis.
  • [MeSH-major] Fibromatosis, Abdominal / pathology. Fibromatosis, Aggressive / pathology
  • [MeSH-minor] Adult. Biomarkers, Tumor / metabolism. Female. Humans. Immunohistochemistry. Male. Neoplasm Recurrence, Local. Prognosis. Risk Factors. Tumor Suppressor Protein p53 / metabolism. beta Catenin / metabolism

  • Genetic Alliance. consumer health - Fibromatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20085516.001).
  • [ISSN] 1465-3931
  • [Journal-full-title] Pathology
  • [ISO-abbreviation] Pathology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CTNNB1 protein, human; 0 / Tumor Suppressor Protein p53; 0 / beta Catenin
  •  go-up   go-down


29. Schlemmer M: Desmoid tumors and deep fibromatoses. Hematol Oncol Clin North Am; 2005 Jun;19(3):565-71, vii-viii

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoid tumors and deep fibromatoses.
  • Desmoid tumors (also called deep fibromatoses) are rare benign tumors associated with pregnancy and Gardner syndrome.
  • These tumors are characterized by bland-appearing fibroblasts, indistinct margins, and an ability to cause pathology by local invasion and recurrence.
  • They arise in the abdominal cavity, in the abdominal wall, or in the extremities/trunk, each with a slightly different biologic behavior.
  • Though they are not cancer and do not metastasize, desmoids can cause significant morbidity and occasionally death through local/regional invasion of critical structures.
  • This article highlights the biology and clinical features of desmoid tumors.
  • [MeSH-major] Fibromatosis, Aggressive. Gardner Syndrome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15939197.001).
  • [ISSN] 0889-8588
  • [Journal-full-title] Hematology/oncology clinics of North America
  • [ISO-abbreviation] Hematol. Oncol. Clin. North Am.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 44
  •  go-up   go-down


30. Ozger H, Eralp L, Toker B, Ağaoğlu F, Dizdar Y: [Evaluation of prognostic factors affecting recurrences and disease-free survival in extra-abdominal desmoid tumors]. Acta Orthop Traumatol Turc; 2007 Aug-Oct;41(4):291-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Evaluation of prognostic factors affecting recurrences and disease-free survival in extra-abdominal desmoid tumors].
  • [Transliterated title] Ekstra-abdominal desmoid tümörlerde nüks ve hastaliksiz sağkalimi etkileyen prognostik faktörlerin değerlendirilmesi.
  • OBJECTIVES: We investigated treatment results and the role of potential prognostic factors in patients treated by surgery with or without adjuvant radiotherapy for primary or recurrent extra-abdominal desmoid tumors.
  • METHODS: The study included 38 patients (23 females, 15 males; mean age 24 years; range 5 to 61 years) who underwent surgical treatment for extra-abdominal desmoid tumors.
  • The mean disease-free survival was 38+/-8 months, and eight-year disease-free survival was 35.7+/-8.5%.
  • Disease-free survival did not differ significantly between patients receiving adjuvant radiotherapy (47.9+/-7.9 months) and those treated with surgery alone (37.9+/-12.4 months), and between patients who developed a recurrence at the resection site (12.1+/-4.7 months) or at a different site (24.3+/-1.0 months) (p>0.05).
  • None of the potential prognostic factors including gender, age, localization, surgical margin, or adjuvant irradiation were found to affect disease-free survival.
  • [MeSH-major] Fibromatosis, Aggressive / surgery. Neoplasm Recurrence, Local / surgery. Soft Tissue Neoplasms / surgery
  • [MeSH-minor] Adolescent. Adult. Axilla. Child. Child, Preschool. Combined Modality Therapy. Disease-Free Survival. Extremities. Female. Humans. Male. Middle Aged. Prognosis. Turkey / epidemiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18180559.001).
  • [ISSN] 1017-995X
  • [Journal-full-title] Acta orthopaedica et traumatologica turcica
  • [ISO-abbreviation] Acta Orthop Traumatol Turc
  • [Language] tur
  • [Publication-type] English Abstract; Evaluation Studies; Journal Article
  • [Publication-country] Turkey
  •  go-up   go-down


31. Ogunsalu C, Barclay S: Aggressive infantile (desmoid-type) fibromatosis of the maxilla: a case report and new classification. West Indian Med J; 2005 Oct;54(5):337-40
Genetic Alliance. consumer health - Fibromatosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Aggressive infantile (desmoid-type) fibromatosis of the maxilla: a case report and new classification.
  • This paper describes the clinical, radiographic and histologic findings of an aggressive infantile (desmoid-type) fibromatosis of the face in a seven-year-old black Jamaican male.
  • The differential diagnosis, management and long term follow-up of this case are also mentioned The need for a less aggressive surgical management in this child and long-term follow-up is stressed.
  • This paper discusses the differential diagnosis and treatment of aggressive infantile fibromatosis and suggests a classification of the condition.
  • [MeSH-major] Fibroma / pathology. Fibroma / surgery. Maxillary Neoplasms / pathology. Maxillary Neoplasms / surgery. Neoplasm Invasiveness / pathology. Surgery, Oral / methods
  • [MeSH-minor] Biopsy, Needle. Child. Follow-Up Studies. Humans. Immunohistochemistry. Male. Neoplasm Staging. Risk Assessment. Treatment Outcome

  • Genetic Alliance. consumer health - Aggressive Fibromatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16459519.001).
  • [ISSN] 0043-3144
  • [Journal-full-title] The West Indian medical journal
  • [ISO-abbreviation] West Indian Med J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Jamaica
  • [Number-of-references] 15
  •  go-up   go-down


32. Kujak JL, Liu PT, Johnson GB, Callstrom MR: Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors. Skeletal Radiol; 2010 Feb;39(2):175-82
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Early experience with percutaneous cryoablation of extra-abdominal desmoid tumors.
  • OBJECTIVE: Surgical resection, radiation therapy and chemotherapy are all accepted as standard treatments for extra-abdominal desmoid (EAD) tumors, but their effectiveness has been limited by frequent local recurrence.
  • The purpose of this article is to describe our early experiences with using percutaneous cryoablation for local control of extra-abdominal desmoid tumors in five patients whose tumors had failed to respond to standard therapy.
  • MATERIAL AND METHODS: In a retrospective search of our institution's radiology database for patients who had undergone percutaneous cryoablation for treatment of EAD tumors between June 2004 and July 2007, we identified five patients (three female and two male).
  • Three of these patients had been referred for cryoablation for local tumor control, and two had been referred for palliation of inoperable tumors.
  • The treated EAD tumors were located in the neck, shoulders and trunk and ranged in size from 3.0 cm to 10.0 cm.
  • Radiology records were reviewed to follow the size of the EAD tumors before and after cryotherapy.
  • RESULTS: For the three patients referred for local control of EAD tumors, complete tumor coverage with the ablation zones was achieved.
  • Their tumors had completely resolved on long-term imaging follow-up at 19 months and 43 months.
  • The third patient, with a 6.1 cm mass, reported improved mild pain at 6 months, and imaging showed a moderate decrease of tumor size.
  • For the two patients referred for palliative therapy, initial partial pain relief was felt 2 weeks after the procedure, At long-term (58 months) follow-up of one patient with a 9.1 cm mass, the tumor was still present although reduced in size, and local pain had returned to its former moderate level.
  • CONCLUSION: Cryoablation appears to be an effective alternative treatment for the achievement of local control of small and moderately sized EAD tumors, but it is likely of limited use in patients with larger tumors that have untreatable regions due to involvement of vital structures.
  • Continued research evaluating cryoablation for the treatment of EAD tumors is needed.
  • [MeSH-major] Cryosurgery / methods. Fibromatosis, Aggressive / diagnosis. Fibromatosis, Aggressive / surgery
  • [MeSH-minor] Abdominal Neoplasms / diagnosis. Abdominal Neoplasms / surgery. Adolescent. Adult. Child. Female. Humans. Male. Pilot Projects. Treatment Outcome. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19768644.001).
  • [ISSN] 1432-2161
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


33. Jilong Y, Jian W, Xiaoyan Z, Xiaoqiu L, Xiongzeng Z: Analysis of APC/beta-catenin genes mutations and Wnt signalling pathway in desmoid-type fibromatosis. Pathology; 2007 Jun;39(3):319-25
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Analysis of APC/beta-catenin genes mutations and Wnt signalling pathway in desmoid-type fibromatosis.
  • OBJECTIVE: The abnormalities of the Wnt signalling pathway in desmoid-type fibromatosis were analysed, with the purpose of exploring the mechanism of tumorigenesis and progression.
  • Using the same materials, apoptosis of the tumour cells was investigated by terminal deoxynucleotidyl transferase mediated dUTP nick end-labelling (TUNEL) testing.
  • CONCLUSIONS: There are somatic mutations of the APC and beta-catenin gene in desmoid-type fibromatosis, and there are abnormalities in the Wnt signalling pathway.
  • [MeSH-major] Fibromatosis, Aggressive / genetics. Genes, APC. Signal Transduction / physiology. Wnt Proteins / metabolism. beta Catenin / genetics

  • Genetic Alliance. consumer health - Fibromatosis.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17558858.001).
  • [ISSN] 0031-3025
  • [Journal-full-title] Pathology
  • [ISO-abbreviation] Pathology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Ki-67 Antigen; 0 / Proto-Oncogene Proteins c-myc; 0 / Wnt Proteins; 0 / beta Catenin; 136601-57-5 / Cyclin D1
  •  go-up   go-down


34. Al-Otaibi ML, Turcotte RE, Hings I, Beaudet J, Isler M, Nahal A, Wong C: Low-dose chemotherapy for extra-abdominal desmoid tumor. Saudi Med J; 2008 Dec;29(12):1730-4
Genetic Alliance. consumer health - Desmoid Tumor.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Low-dose chemotherapy for extra-abdominal desmoid tumor.
  • OBJECTIVE: To assess the outcome of patients with extra-abdominal desmoid tumor treated with low dose chemotherapy (methotrexate and vinblastine) both for tumor response and treatment related toxicity.
  • METHODS: We retrospectively reviewed the outcome of 12 patients who underwent low dose chemotherapy for extra abdominal desmoid of different locations.
  • We evaluated the patients for their compliance, tumor response, complications of treatment, and impact of treatment on symptoms.
  • RESULTS: Disease related morbidity included pain in 7 patients, functional limitation in 7 and cosmetic defects in 3.
  • The mean tumor size was 11 cm (3-20 cm).
  • According to Response Evaluation Criteria in Solid Tumors, 6 tumors showed a partial response and 6 remained stable.
  • Of the 7 patients who had painful tumors, 6 achieved significant symptom relief.
  • At latest follow-up, tumors remained stable in 8, one has markedly regressed and 3 exhibited progression at an average of 54 months.
  • [MeSH-major] Antineoplastic Agents / administration & dosage. Fibroma / drug therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19082222.001).
  • [ISSN] 0379-5284
  • [Journal-full-title] Saudi medical journal
  • [ISO-abbreviation] Saudi Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Saudi Arabia
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


35. de Camargo VP, Keohan ML, D'Adamo DR, Antonescu CR, Brennan MF, Singer S, Ahn LS, Maki RG: Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor). Cancer; 2010 May 1;116(9):2258-65
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor).
  • BACKGROUND: In the current study, the authors examined the outcomes of patients with desmoid tumors who received systemic therapy at a single institution to provide a basis for the examination of newer agents.
  • METHODS: Records of patients with desmoid tumors who were treated with chemotherapy at the study institution were reviewed.
  • Patients without measurable disease and those receiving therapy could not be documented, and those receiving prophylactic therapy were excluded.
  • At the time of last follow-up, 9 patients had died, 7 of progressive disease.
  • An intra-abdominal primary tumor location was the most common (44%).
  • The greatest Response Evaluation Criteria in Solid Tumors (RECIST) response rate was observed with anthracyclines and hormonal therapy and the lowest response was noted with single-agent dacarbazine/temozolomide or tyrosine kinase inhibitors, principally imatinib.
  • On multivariate analysis, macroscopic nodular morphology and the presence of Gardner syndrome were the only tumor factors found to be associated with a greater time to disease progression.
  • CONCLUSIONS: Compared with other agents, antiestrogens and anthracycline-containing regimens appear to be associated with a higher radiological response rate against desmoid tumors.
  • Systemic therapy can be successful in patients with desmoid tumors, and is a viable option in lieu of morbid or disabling surgery.

  • Genetic Alliance. consumer health - Desmoid Tumor.
  • Genetic Alliance. consumer health - Fibromatosis.
  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2010 American Cancer Society.
  • [Cites] Oncogene. 1999 Nov 11;18(47):6615-20 [10597266.001]
  • [Cites] Am J Pathol. 2008 Nov;173(5):1518-27 [18832571.001]
  • [Cites] Cancer. 2003 Feb 15;97(4):1134-5 [12569616.001]
  • [Cites] J Clin Oncol. 2003 May 1;21(9):1698-707 [12721244.001]
  • [Cites] Cancer. 2004 Feb 1;100(3):612-20 [14745880.001]
  • [Cites] Cancer. 1981 Jan 1;47(1):207-14 [7459811.001]
  • [Cites] Surgery. 1993 Nov;114(5):902-6 [8236012.001]
  • [Cites] Cancer. 1993 Dec 1;72(11):3244-7 [8242548.001]
  • [Cites] Hum Mol Genet. 1995 Mar;4(3):337-40 [7795585.001]
  • [Cites] Hum Mol Genet. 1996 Dec;5(12):1921-4 [8968744.001]
  • [Cites] Diagn Mol Pathol. 1997 Apr;6(2):98-101 [9098648.001]
  • [Cites] Am J Pathol. 1997 Aug;151(2):329-34 [9250146.001]
  • [Cites] Ann Surg. 1999 Jun;229(6):866-72; discussion 872-3 [10363901.001]
  • [Cites] Br J Surg. 1999 Sep;86(9):1185-9 [10504375.001]
  • [Cites] J Clin Oncol. 2006 Jan 1;24(1):102-5 [16382119.001]
  • [Cites] J Clin Oncol. 2006 Mar 1;24(7):1195-203 [16505440.001]
  • [Cites] J Clin Oncol. 2007 May 1;25(13):1785-91 [17470870.001]
  • [Cites] Clin Gastroenterol Hepatol. 2008 Feb;6(2):215-9 [18237870.001]
  • [Cites] Eur J Surg Oncol. 2008 Apr;34(4):462-8 [17709227.001]
  • [Cites] J Am Acad Orthop Surg. 2008 Apr;16(4):188-98 [18390481.001]
  • [Cites] Clin Cancer Res. 2008 May 1;14(9):2717-25 [18451237.001]
  • [Cites] J Natl Cancer Inst. 2000 Feb 2;92(3):205-16 [10655437.001]
  • (PMID = 20187095.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / RC2 CA148260-01; United States / NCI NIH HHS / CA / P01 CA47179; United States / NCI NIH HHS / CA / P01 CA047179-15A2; United States / CCR NIH HHS / RC / CA148260-01; United States / NCI NIH HHS / CA / P01 CA047179
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  • [Other-IDs] NLM/ NIHMS219553; NLM/ PMC2925106
  •  go-up   go-down


36. Amary MF, Pauwels P, Meulemans E, Roemen GM, Islam L, Idowu B, Bousdras K, Diss TC, O'Donnell P, Flanagan AM: Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool. Am J Surg Pathol; 2007 Sep;31(9):1299-309
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.
  • Desmoid-type fibromatosis is a locally aggressive deep soft tissue tumor.
  • The aim of this study was to determine the specificity and sensitivity of these 3 most common beta-catenin mutations in the diagnosis of desmoid-type fibromatosis using paraffin-embedded material.
  • One hundred and thirty-three cases were analyzed, including 76 desmoid-type, and 18 superficial fibromatosis, in addition to a further 39 fibromatosis mimics.
  • Mutations were detected in 66 cases (87%) of 76 desmoid-type fibromatosis (71 extra-abdominal).
  • All desmoid-type fibromatosis cases and 72% of the mimics tested showed nuclear positivity for beta-catenin indicating immunohistochemistry is a sensitive but not a specific test for desmoid-type fibromatosis.
  • In contrast, to date, beta-catenin mutations have not been detected in any lesions which mimic desmoid-type fibromatosis.
  • Mutation-specific restriction enzyme digestion, a simple and efficient means of detecting the common beta-catenin mutations in desmoid-type fibromatosis, complements light microscopy in reaching a diagnosis.
  • [MeSH-major] DNA Mutational Analysis / methods. Fibromatosis, Aggressive / diagnosis. Gene Expression Regulation, Neoplastic. Mutation. Restriction Mapping. beta Catenin / genetics
  • [MeSH-minor] Adolescent. Adult. Aged. Base Sequence. Cell Nucleus / chemistry. Child. Codon. Diagnosis, Differential. Female. Humans. Immunohistochemistry / methods. Magnetic Resonance Imaging. Male. Middle Aged. Molecular Sequence Data. Paraffin Embedding. Predictive Value of Tests. Sensitivity and Specificity. Tissue Array Analysis

  • Genetic Alliance. consumer health - Fibromatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17721184.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CTNNB1 protein, human; 0 / Codon; 0 / beta Catenin
  •  go-up   go-down


37. Ridders J, Ernst A, Todt I, Seidl RO: [Extra-abdominal desmoid tumors. Case report and literature review]. HNO; 2005 Jul;53(7):639-44
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Extra-abdominal desmoid tumors. Case report and literature review].
  • [Transliterated title] Extraabdominelle Fibromatose. Fallbericht und Literaturübersicht.
  • Musculoaponeurotic fibromatosis or desmoid tumors are rare.
  • We report the case of a 57 year old woman with a slowly growing tumor behind the sternocleidomastoid muscle, which was completely removed.
  • Histological examination confirmed the clinical suspicion of a desmoid tumor.
  • Desmoid tumors are aggressive, locally infiltrating, non-metastasizing tumors with a high local recurrence.
  • The diagnosis is made histologically, reactive fibromatosis and fibrosarcoma must be eliminated in differential diagnosis.
  • By the combination of different radiographic techniques, it is possible to describe the tumors and differentiate between vessels, nerves and bones.
  • Adjuvant therapy, such as x-ray treatment, chemo- and hormone therapy, are indicated when the tumor is inoperable or too extensive for surgery.
  • [MeSH-major] Fibromatosis, Aggressive / diagnosis. Head and Neck Neoplasms / diagnosis
  • [MeSH-minor] Abdominal Neoplasms / diagnosis. Abdominal Neoplasms / pathology. Abdominal Neoplasms / surgery. Adult. Calcinosis / diagnosis. Calcinosis / pathology. Calcinosis / surgery. Diagnosis, Differential. Disease Progression. Female. Humans. Magnetic Resonance Imaging. Neck Muscles / pathology. Neck Muscles / surgery. Tomography, X-Ray Computed. Ultrasonography

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15257395.001).
  • [ISSN] 0017-6192
  • [Journal-full-title] HNO
  • [ISO-abbreviation] HNO
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


38. de Bree E, Keus R, Melissas J, Tsiftsis D, van Coevorden F: Desmoid tumors: need for an individualized approach. Expert Rev Anticancer Ther; 2009 Apr;9(4):525-35
ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoid tumors: need for an individualized approach.
  • Desmoid tumor, also known as aggressive fibromatosis or desmoid-type fibromatosis, is a rare monoclonal, fibroblastic proliferation arising in musculoaponeurotic structures.
  • Although histologically benign, desmoids are often locally invasive and associated with a high local recurrence rate after resection.
  • Since it is a heterogeneous disease, in particular regarding clinical presentation, anatomic location and biological behavior, treatment should be individualized to reduce local tumor control failure with concurrently acceptable morbidity and preservation of quality of life.
  • Many issues regarding optimal treatment of desmoids remain controversial.
  • Radiotherapy for gross disease is considerably effective, but is associated with a relatively high rate of complications, which are usually mild or moderate and radiation dose dependent.
  • Risk factors for local tumor control failure include young age, large size, presentation as recurrent disease, limb/girdle or intra-abdominal location, involved surgical margins, omission of radiotherapy, radiation dose less than 50 Gy and insufficient radiation field size.
  • Increased comprehension of the pathogenesis and biological behavior of desmoids resulted in the emerging applicability of systemic therapies and a wait-and-see policy.
  • Considering the significant morbidity of surgery and/or radiotherapy for certain locations, especially mutilation and loss of function, and the tumor's natural history, which is often characterized by prolonged periods of stability or even regression, a period of watchful waiting may compose the most appropriate management in selected asymptomatic patients.
  • Attempts to complete eradication of the disease may be worse than the disease itself.
  • [MeSH-major] Fibromatosis, Aggressive / therapy
  • [MeSH-minor] Adult. Age Factors. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Case Management. Child. Combined Modality Therapy. Cyclooxygenase 2 Inhibitors / therapeutic use. Female. Humans. Male. Neoplasm Recurrence, Local. Pregnancy. Pregnancy Complications, Neoplastic / surgery. Radiotherapy / adverse effects. Radiotherapy, Adjuvant. Referral and Consultation. Risk Factors

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19374605.001).
  • [ISSN] 1744-8328
  • [Journal-full-title] Expert review of anticancer therapy
  • [ISO-abbreviation] Expert Rev Anticancer Ther
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Cyclooxygenase 2 Inhibitors
  • [Number-of-references] 89
  •  go-up   go-down


39. Papagelopoulos PJ, Mavrogenis AF, Mitsiokapa EA, Papaparaskeva KT, Galanis EC, Soucacos PN: Current trends in the management of extra-abdominal desmoid tumours. World J Surg Oncol; 2006;4:21

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Current trends in the management of extra-abdominal desmoid tumours.
  • Extra-abdominal desmoid tumours are slow-growing, histologically benign tumours of fibroblastic origin with variable biologic behaviour.
  • They are locally aggressive and invasive to surrounding anatomic structures.
  • Magnetic resonance imaging is the modality of choice for the diagnosis and the evaluation of the tumours.
  • Current management of desmoids involves a multidisciplinary approach.
  • Wide margin surgical resection remains the main treatment modality for local control of the tumour.
  • Chemotherapy may be used for recurrent or unresectable disease.
  • Overall local recurrence rates vary and depend on patient's age, tumour location and margins at resection.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Hum Pathol. 1980 Jan;11(1):43-50 [7364438.001]
  • [Cites] Cancer. 1994 Aug 15;74(4):1270-4 [7519966.001]
  • [Cites] J Clin Oncol. 1995 Nov;13(11):2813-8 [7595743.001]
  • [Cites] Surgery. 1993 Nov;114(5):902-6 [8236012.001]
  • [Cites] J Pediatr Surg. 1993 Nov;28(11):1446-50 [8301457.001]
  • [Cites] Plast Reconstr Surg. 1993 Aug;92(2):335-9 [8337285.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1993 Aug 1;26(5):851-8 [8344854.001]
  • [Cites] Cancer. 1993 Sep 1;72(5):1637-41 [8348495.001]
  • [Cites] J Clin Gastroenterol. 1993 Apr;16(3):264-5 [8505507.001]
  • [Cites] Eur J Radiol. 1993 Apr;16(3):230-2 [8508843.001]
  • [Cites] Cancer. 1996 Mar 15;77(6):1061-5 [8635124.001]
  • [Cites] Urology. 1996 May;47(5):756-9 [8650880.001]
  • [Cites] J Bone Joint Surg Am. 1996 Jun;78(6):848-54 [8666602.001]
  • [Cites] Cancer. 1996 Sep 1;78(5):1011-23 [8780539.001]
  • [Cites] Hum Pathol. 1996 Sep;27(9):939-43 [8816889.001]
  • [Cites] Dis Colon Rectum. 1997 Jul;40(7):798-801 [9221855.001]
  • [Cites] Am J Pathol. 1997 Aug;151(2):329-34 [9250146.001]
  • [Cites] Surg Oncol Clin N Am. 1997 Oct;6(4):847-62 [9309097.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1997 Oct 1;39(3):659-65 [9336146.001]
  • [Cites] J Clin Gastroenterol. 1997 Jul;25(1):334-7 [9412915.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1998 Feb 1;40(3):637-45 [9486614.001]
  • [Cites] Am J Pathol. 1998 Sep;153(3):709-14 [9736021.001]
  • [Cites] J Clin Oncol. 1998 Sep;16(9):3021-7 [9738571.001]
  • [Cites] Acta Oncol. 1998;37(4):331-8 [9743454.001]
  • [Cites] J Pediatr Orthop. 1999 Nov-Dec;19(6):776-84 [10573349.001]
  • [Cites] Acta Oncol. 1999;38(7):971-2 [10606429.001]
  • [Cites] J Surg Oncol. 2000 Jan;73(1):21-5 [10649274.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Jul 15;47(5):1267-71 [10889380.001]
  • [Cites] Cytokines Cell Mol Ther. 2000 Sep;6(3):155-6 [11140885.001]
  • [Cites] J Surg Oncol. 1983 Mar;22(3):197-211 [6220180.001]
  • [Cites] Cancer. 2001 Sep 1;92(5):1259-64 [11571741.001]
  • [Cites] Genes Chromosomes Cancer. 2002 Jul;34(3):255-68 [12007186.001]
  • [Cites] Cancer. 2003 Feb 15;97(4):1134-5 [12569616.001]
  • [Cites] Cancer. 1954 Sep;7(5):953-78 [13199773.001]
  • [Cites] Int Orthop. 2004 Aug;28(4):252-6 [15168085.001]
  • [Cites] J Pediatr Hematol Oncol. 2004 Aug;26(8):518-22 [15284591.001]
  • [Cites] Int J Oral Maxillofac Surg. 2004 Sep;33(6):606-9 [15308262.001]
  • [Cites] Ann Thorac Surg. 2004 Oct;78(4):1219-23; discussion 1219-23 [15464474.001]
  • [Cites] Med Hypotheses. 2005;64(2):333-6 [15607567.001]
  • [Cites] J Clin Oncol. 2006 Jan 1;24(1):102-5 [16382119.001]
  • [Cites] Surgery. 1976 Jan;79(1):104-6 [128840.001]
  • [Cites] Pediatr Radiol. 1992;22(8):587-9 [1491936.001]
  • [Cites] Cancer. 1991 Sep 15;68(6):1384-8 [1831400.001]
  • [Cites] Clin Orthop Relat Res. 1991 Jan;(262):58-63 [1984932.001]
  • [Cites] Cancer. 1991 Jan 15;67(2):380-4 [1985733.001]
  • [Cites] Cancer. 1991 Mar 1;67(5):1443-6 [1991311.001]
  • [Cites] Am J Surg. 1991 Apr;161(4):416-21 [2035759.001]
  • [Cites] Clin Radiol. 1990 Sep;42(3):170-3 [2208926.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1990 Mar;18(3):535-40 [2318685.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1990 Jul;19(1):37-40 [2380093.001]
  • [Cites] Ann Surg. 1989 Dec;210(6):765-9 [2531573.001]
  • [Cites] Cancer. 1987 Dec 15;60(12):2863-8 [2824015.001]
  • [Cites] Arch Surg. 1989 Feb;124(2):191-6 [2916941.001]
  • [Cites] Pediatrics. 1987 Mar;79(3):394-8 [3103093.001]
  • [Cites] Am J Surg. 1988 Jun;155(6):754-60 [3132051.001]
  • [Cites] Skeletal Radiol. 1988;17(1):16-9 [3358131.001]
  • [Cites] Arch Surg. 1987 Nov;122(11):1296-8 [3675193.001]
  • [Cites] Eur J Cancer Clin Oncol. 1986 May;22(5):583-7 [3770030.001]
  • [Cites] Am J Surg. 1986 Feb;151(2):230-7 [3946757.001]
  • [Cites] J Bone Joint Surg Br. 1973 Nov;55(4):858-63 [4766193.001]
  • [Cites] Cancer. 1967 Jul;20(7):1131-40 [6027003.001]
  • [Cites] Am J Surg. 1982 Oct;144(4):437-44 [6289687.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1983 Aug;9(8):1167-71 [6409853.001]
  • [Cites] Cancer. 1984 Nov 15;54(10):2051-5 [6488135.001]
  • [Cites] Cancer. 1983 Dec 15;52(12):2201-4 [6640490.001]
  • (PMID = 16584569.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1456964
  •  go-up   go-down


40. Matono H, Oda Y, Nakamori M, Tamiya S, Yamamoto H, Yokoyama R, Saito T, Iwamoto Y, Tsuneyoshi M: Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors. Hum Pathol; 2008 Dec;39(12):1802-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
  • Desmoid tumors (desmoid-type fibromatoses) are locally aggressive soft tissue tumors associated with the Wnt/beta-catenin signaling pathway (APC-beta-catenin-Tcf pathway).
  • Matrix metalloproteinase-7, which is one of the target genes of the Wnt/beta-catenin signaling pathway, has been reported to play an important role in tumor progression.
  • We examined the immunohistochemical expression of beta-catenin and matrix metalloproteinase-7 in 72 samples (63 primary and 9 recurrent samples, 63 patients) of sporadic desmoid tumors without familial adenomatous polyposis, and the genetic alteration of the beta-catenin gene in 33 frozen materials (22 primary and 11 recurrent samples, 22 patients).
  • Immunohistochemically, there was a statistically significant correlation between widespread nuclear expression of beta-catenin and overexpression of matrix metalloproteinase-7 (P < .01 in extra-abdominal desmoid, Fisher test).
  • In the beta-catenin mutated group, matrix metalloproteinase-7 messenger RNA expression was significantly higher than that of the beta-catenin wild-type group (P = .0018, Mann-Whitney U test).
  • Our results suggest that the matrix metalloproteinase-7 gene may be up-regulated by mutated or continuously elevated beta-catenin protein and that the matrix metalloproteinase-7 gene may also be targeted in the Wnt/beta-catenin signaling pathway in sporadic desmoid tumors.
  • [MeSH-major] Fibromatosis, Aggressive / metabolism. Gene Expression Regulation, Neoplastic. Matrix Metalloproteinase 7 / metabolism. Soft Tissue Neoplasms / metabolism. beta Catenin / metabolism
  • [MeSH-minor] Adolescent. Adult. Aged. Biomarkers, Tumor / genetics. Biomarkers, Tumor / metabolism. Cell Nucleus / metabolism. Child. Child, Preschool. Female. Humans. Infant. Male. Middle Aged. Mutation, Missense. RNA, Messenger / metabolism. RNA, Neoplasm / analysis. Reverse Transcriptase Polymerase Chain Reaction. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18715618.001).
  • [ISSN] 1532-8392
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CTNNB1 protein, human; 0 / RNA, Messenger; 0 / RNA, Neoplasm; 0 / beta Catenin; EC 3.4.24.23 / MMP7 protein, human; EC 3.4.24.23 / Matrix Metalloproteinase 7
  •  go-up   go-down


41. Seinfeld J, Kleinschmidt-Demasters BK, Tayal S, Lillehei KO: Desmoid-type fibromatoses involving the brachial plexus: treatment options and assessment of c-KIT mutational status. J Neurosurg; 2006 May;104(5):749-56
Hazardous Substances Data Bank. IMATINIB MESYLATE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoid-type fibromatoses involving the brachial plexus: treatment options and assessment of c-KIT mutational status.
  • OBJECT: Desmoid-type fibromatoses are a locally invasive soft-tissue lesion that is most commonly encountered in abdominal sites.
  • The tumor also affects head and neck areas, particularly the supraclavicular region, where it may encase and distort the brachial plexus and compromise neurovascular structures.
  • Neurosurgeons may be called on to treat desmoid-type fibromatoses in these sites.
  • The authors describe their experience in treating four patients with desmoid-type fibromatoses involving the brachial plexus and report the results of immunohistochemical analysis of the tumors.
  • Intraoperative identification of the site of tumor origin from musculoaponeurotic tissues by the neurosurgeon was necessary in two of the four cases to achieve a correct frozen section or final pathological diagnosis.
  • Immunostaining for c-KIT (CD117) was undertaken in all cases in light of a previous report of positive CD117 immunoreactivity in abdominal desmoid-type fibromatoses.
  • All four tumors manifested weak focal immunostaining for c-KIT.
  • Subsequent polymerase chain reaction testing revealed that three of the four tumors manifested a single base pair change in exon 10 of the c-KIT gene (A to C in two cases and A to G in one case).
  • With the combination of surgery and radiation therapy, local disease control was achieved in three of the four patients.
  • CONCLUSIONS: This represents the first report of c-KIT sequencing in desmoid-type fibromatoses and suggests a possible biological basis for continuing to explore the use of adjuvant imatinib mesylate therapy.
  • [MeSH-major] Brachial Plexus Neuropathies / surgery. DNA Mutational Analysis. Fibromatosis, Aggressive / surgery. Peripheral Nervous System Neoplasms / surgery. Proto-Oncogene Proteins c-kit / genetics
  • [MeSH-minor] Adult. Base Pair Mismatch / genetics. Benzamides. Brachial Plexus / pathology. Brachial Plexus / surgery. Chemotherapy, Adjuvant. Combined Modality Therapy. Exons / genetics. Female. Humans. Imatinib Mesylate. Male. Middle Aged. Neoplasm Recurrence, Local / diagnosis. Neoplasm Recurrence, Local / genetics. Neoplasm Recurrence, Local / surgery. Piperazines / therapeutic use. Polymerase Chain Reaction. Pyrimidines / therapeutic use. Reoperation

  • MedlinePlus Health Information. consumer health - Brachial Plexus Injuries.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Neurosurg. 2007 Aug;107(2):473-5; author reply 475 [17695408.001]
  • (PMID = 16703880.001).
  • [ISSN] 0022-3085
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Benzamides; 0 / Piperazines; 0 / Pyrimidines; 8A1O1M485B / Imatinib Mesylate; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit
  •  go-up   go-down


42. Mátrai Z, Papp J, Polgár C, Hitre E, Köves I, Oláh E, Andi J, Kiss A, Vámosi Nagy I, Tóth L, Orosz Z: [Long-term experience with therapy of a female patient with Gardner's syndrome, first presenting with extra-abdominal desmoid tumor, and review of the literature]. Magy Seb; 2009 Apr;62(2):75-82
MedlinePlus Health Information. consumer health - Cancer Chemotherapy.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Long-term experience with therapy of a female patient with Gardner's syndrome, first presenting with extra-abdominal desmoid tumor, and review of the literature].
  • [Transliterated title] Extraabdominalis desmoid tumorral megjeleno Gardner-syndromás beteg kezelésével szerzett hosszú távú tapasztalataink és irodalmi áttekintés.
  • Gardner's syndrome is a clinical subgroup of familial adenomatous polyposis, an autosomal dominant disease.
  • It is characterized by gastrointestinal polyps and extra-intestinal manifestations including multiple osteomas, skin and soft tissue tumours.
  • Aggressive desmoid tumours can be very difficult to manage in patients with Gardner's syndrome.
  • We present a case of a 17-year-old female who presented with an aggressive desmoid tumor arising of the lumbar area as part of her Gardner's syndrome.
  • We conclude that desmoid tumors can precede gastrointestinal manifestations of familial adenomatous polyposis or Gardner's syndrome.
  • Desmoid tumours should be managed in a multidisciplinary setting, as well.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Fibromatosis, Aggressive / diagnosis. Fibromatosis, Aggressive / genetics. Gardner Syndrome / diagnosis. Gardner Syndrome / genetics. Genes, APC
  • [MeSH-minor] Adolescent. Antineoplastic Agents, Hormonal / therapeutic use. Base Sequence. Female. Germ-Line Mutation. Humans. Molecular Sequence Data. Neoplasm Staging. Polymorphism, Genetic

  • Genetic Alliance. consumer health - Desmoid Tumor.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19386568.001).
  • [ISSN] 0025-0295
  • [Journal-full-title] Magyar sebészet
  • [ISO-abbreviation] Magy Seb
  • [Language] hun
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Hungary
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Antineoplastic Agents, Hormonal
  • [Number-of-references] 30
  •  go-up   go-down


43. Shimoyama T, Hiraoka K, Shoda T, Hamada T, Fukushima N, Nagata K: Multicentric extra-abdominal desmoid tumors arising in bilateral lower limbs. Rare Tumors; 2010;2(1):e12

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multicentric extra-abdominal desmoid tumors arising in bilateral lower limbs.
  • Extra-abdominal desmoid tumors preferentially affect the shoulders, arms, backs, buttocks, and thighs of young adults.
  • Multicentric occurrence is rather rare but seems to be another distinctive feature of extra-abdominal desmoid tumors.
  • In this article we report a rare case of multicentric extra-abdominal desmoid tumors arising in bilateral lower limbs.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21139941.001).
  • [ISSN] 2036-3613
  • [Journal-full-title] Rare tumors
  • [ISO-abbreviation] Rare Tumors
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Other-IDs] NLM/ PMC2994500
  • [Keywords] NOTNLM ; bilateral limbs / desmoid / radiation
  •  go-up   go-down


44. Matsuo T, Hiyama E, Sugita T, Shimose S, Kubo T, Mochizuki Y, Adachi N, Ochi M: Telomere length and telomerase activity in extra-abdominal desmoid tumors. Anticancer Res; 2007 Jan-Feb;27(1A):411-5
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Telomere length and telomerase activity in extra-abdominal desmoid tumors.
  • The telomere biology of extra-abdominal desmoids was investigated.
  • There was a significant correlation between telomere length and tumor size, with telomeres being shorter with increasing tumor size (p = 0.049), and between telomere length and PCNA-positive cell rate, with telomere shortening with increased positive cell rate (p = 0.017).
  • Telomere length increased with recurrence, but telomerase activity decreased, and rate of PCNA-positive cells became lower, whenever the tumors were recurrent.
  • Decreasing telomere length correlated with tumor size, probably due to increased duration of proliferation in the tumor, and tumor aggressiveness.
  • [MeSH-major] Fibromatosis, Aggressive / enzymology. Fibromatosis, Aggressive / genetics. Telomerase / metabolism. Telomere / metabolism
  • [MeSH-minor] Adolescent. Adult. Aged. Female. Humans. Immunohistochemistry. Male. Middle Aged. Neoplasm Recurrence, Local / enzymology. Neoplasm Recurrence, Local / genetics. Neoplasm Recurrence, Local / pathology. Proliferating Cell Nuclear Antigen / metabolism

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17352261.001).
  • [ISSN] 0250-7005
  • [Journal-full-title] Anticancer research
  • [ISO-abbreviation] Anticancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Proliferating Cell Nuclear Antigen; EC 2.7.7.49 / Telomerase
  •  go-up   go-down


45. Neuman HB, Brogi E, Ebrahim A, Brennan MF, Van Zee KJ: Desmoid tumors (fibromatoses) of the breast: a 25-year experience. Ann Surg Oncol; 2008 Jan;15(1):274-80
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoid tumors (fibromatoses) of the breast: a 25-year experience.
  • BACKGROUND: Breast desmoid tumors are rare and often clinically mistaken for carcinoma.
  • We reviewed our 25-year institutional experience with breast desmoid tumors.
  • METHODS: A search of pathology and sarcoma databases (1982-2006) identified 32 patients with pathologically confirmed breast desmoids.
  • Eight patients (25%) had prior history of breast cancer and 14 (44%) of breast surgery, with desmoids diagnosed a median of 24 months postoperatively.
  • Treatment was surgical, with median tumor size of 2.5 cm (range, 0.3-15).
  • Eight patients (29%) had recurring tumors at a median 15 months.
  • Patients with recurring tumors were younger (median age: 28 vs. 46 years, p = 0.03).
  • A trend toward more frequent recurrences in patients with positive (5/9 patients) versus negative (3/19 patients) margins (p = 0.07) and larger tumors (p = 0.12) was observed.
  • CONCLUSIONS: In our series, breast desmoids presented as palpable masses suspicious for carcinoma clinically and radiographically.
  • Recurrences are common, with younger age and possibly positive margin status and larger tumor size associated with increased risk of recurrence.
  • [MeSH-major] Breast Neoplasms / pathology. Fibromatosis, Aggressive / pathology
  • [MeSH-minor] Adult. Aged. Female. Humans. Mammography. Mastectomy. Middle Aged. Neoplasm Recurrence, Local / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17896146.001).
  • [ISSN] 1534-4681
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Grant] United States / AHRQ HHS / HS / 5 T32 HS000066
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  •  go-up   go-down


46. Agrawal PS, Jagtap SM, Mitra SR: Extra-abdominal desmoid tumour of the leg. Singapore Med J; 2008 Jan;49(1):e6-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extra-abdominal desmoid tumour of the leg.
  • Extra-abdominal desmoid tumour is a rare tumour and only a few cases occurring in the limbs have been reported.
  • She had a mild, dull, aching pain in the tumour.
  • Wide local excision was done and the tumour was found mainly in the subcutaneous tissue, which histopathologically proved to be an extra-abdominal desmoid tumour.
  • This case had an abnormal radiological appearance of peripheral calcification of tumour and saucer-shaped lesion in the underlying tibial cortex.
  • [MeSH-major] Fibromatosis, Aggressive / diagnosis. Leg / pathology. Soft Tissue Neoplasms / diagnosis
  • [MeSH-minor] Adult. Biopsy. Disease-Free Survival. Female. Humans. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18204758.001).
  • [ISSN] 0037-5675
  • [Journal-full-title] Singapore medical journal
  • [ISO-abbreviation] Singapore Med J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Singapore
  •  go-up   go-down


47. Paradol PO, Toussoun G, Delbaere M, Delaporte T, Delay E: [Extra-abdominal desmoid tumor in a scar of donor-site of a latissimus dorsi flap: case report]. Ann Chir Plast Esthet; 2008 Feb;53(1):63-9
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Extra-abdominal desmoid tumor in a scar of donor-site of a latissimus dorsi flap: case report].
  • [Transliterated title] Tumeur desmoïde extra-abdominale survenue sur cicatrice de prélèvement de lambeau de grand dorsal: à propos d'un cas.
  • We will discuss one case of desmoid tumor arising from a latissimus dorsi flap donor-site scar.
  • A dorsal tumefaction, with a benign aspect, was observed during the follow-up period.
  • The biopsy showed an extra-abdominal desmoid tumor.
  • [MeSH-major] Cicatrix / complications. Fibromatosis, Aggressive / etiology. Mammaplasty / adverse effects. Skin Neoplasms / etiology. Surgical Flaps / adverse effects

  • Genetic Alliance. consumer health - Desmoid Tumor.
  • MedlinePlus Health Information. consumer health - Breast Reconstruction.
  • MedlinePlus Health Information. consumer health - Scars.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17418929.001).
  • [ISSN] 0294-1260
  • [Journal-full-title] Annales de chirurgie plastique et esthétique
  • [ISO-abbreviation] Ann Chir Plast Esthet
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


48. Suresh CS, Ali AA: Desmoid tumor of the tongue. Med Oral Patol Oral Cir Bucal; 2008 Dec;13(12):E761-4
Genetic Alliance. consumer health - Desmoid Tumor.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoid tumor of the tongue.
  • Desmoid tumors are rare neoplasms accounting for 0.03% of all neoplasms and have an estimated incidence of 2 to 4 per million per year.
  • World Health Organization currently refers to all of the deep types of fibromatosis as desmoid-type of fibromatoses.
  • The term "desmoid" refers to the hard, tendon-like appearance of the tumor.
  • About fifty percent of desmoid tumors arise in the abdominal region.
  • The extra-abdominal desmoid tumors present a difficult problem in recognition and management especially because of the striking discrepancy between its deceptively harmless microscopic appearance and its potential to attain a large size, to recur, and to infiltrate neighboring tissues in the manner of a fibrosarcoma.
  • Desmoid tumors are very rare in the oral cavity with less than 5% of cases constituting oral soft tissue fibromatosis.
  • A 22-year old mentally retarded female patient with desmoid tumor occurring in the tongue is presented here.
  • [MeSH-major] Fibromatosis, Aggressive / pathology. Tongue Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19047962.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


49. Rosato L, Mondini G, Serbelloni M, Bertone P, Orlassino R, Cossavella D: [Intra-abdominal desmoid tumors: rare but important disease]. G Chir; 2007 Jan-Feb;28(1-2):20-4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intra-abdominal desmoid tumors: rare but important disease].
  • Desmoid tumors are rare benign neoplasms with high tendency to local recurrence, and they can be divided into extra- and intra-abdominal types (mesenteric fibromatosis).
  • Six patients (3 men and 3 women) affected by extra-abdominal desmoid tumors have been treated with radical excision.
  • In two patients desmoid was intra-abdominal:.
  • 2) 52 years old man, submitted to an elective excision of a capsulated neoplasm of the little omentum, which had caused an oppressive abdominal pain.
  • In both cases the hystological diagnosis has been desmoid tumor.
  • Surgical treatment of desmoid tumors must aim at radical excision to avoid frequent recurrences (25-65%); these have stimulated the research of other kinds of treatments, since a new surgical operation itself can lead to a further recurrence.
  • Radiotherapy has been investigated with results in 79-96% of cases, antiestrogenic therapy has been used with success in 51% of patients, and high dose tamoxifen seemed to obtain a stable disease in non operable cases.
  • Conclusive results on the efficacy of these treatments have not been obtained yet, because of the rarity of the desmoid tumors even in greater Centres.
  • [MeSH-major] Fibromatosis, Abdominal / surgery. Mesentery. Peritoneal Neoplasms / surgery
  • [MeSH-minor] Abdominal Neoplasms / pathology. Abdominal Neoplasms / surgery. Aged. Female. Fibromatosis, Aggressive / surgery. Humans. Male. Middle Aged. Retrospective Studies. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17313728.001).
  • [ISSN] 0391-9005
  • [Journal-full-title] Il Giornale di chirurgia
  • [ISO-abbreviation] G Chir
  • [Language] ita
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


50. Seper L, Hoppe P, Kruse-Lösler B, Büchter A, Joos U, Kleinheinz J: [Aggressive fibromatosis in the jaw and facial region with bone involvement. A review]. Mund Kiefer Gesichtschir; 2005 Nov;9(6):349-62
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Aggressive fibromatosis in the jaw and facial region with bone involvement. A review].
  • [Transliterated title] Aggressive Fibromatose im Kiefer-Gesichts-Bereich mit ossärer Beteiligung. Eine Ubersicht.
  • BACKGROUND: Aggressive fibromatosis (AF) involving bones of the head is rare and surgery is often complicated by a high recurrence rate.
  • [MeSH-major] Eyelid Neoplasms / diagnosis. Facial Neoplasms / diagnosis. Fibromatosis, Aggressive / diagnosis. Fibromatosis, Gingival / diagnosis. Jaw Neoplasms / diagnosis. Skull Neoplasms / diagnosis
  • [MeSH-minor] Aged. Female. Humans. Neoplasm Recurrence, Local / diagnosis. Neoplasm Recurrence, Local / surgery. Patient Care Team. Radiography, Panoramic. Reoperation. Surgery, Plastic

  • Genetic Alliance. consumer health - Aggressive Fibromatosis.
  • Genetic Alliance. consumer health - Fibromatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16142459.001).
  • [ISSN] 1432-9417
  • [Journal-full-title] Mund-, Kiefer- und Gesichtschirurgie : MKG
  • [ISO-abbreviation] Mund Kiefer Gesichtschir
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article; Meta-Analysis
  • [Publication-country] Germany
  •  go-up   go-down


51. Desai SR, Dombale VD, Janugade HB: Infantile fibromatosis (desmoid type)--a case report. Indian J Pathol Microbiol; 2005 Jul;48(3):379-80
Genetic Alliance. consumer health - Fibromatosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Infantile fibromatosis (desmoid type)--a case report.
  • Infantile fibromatosis represents the childhood counter part of musculoaponeurotic fibromatosis & arises as a solitary mass in skeletal muscle, adjacent fascia, aponeurosis or periosteum.
  • Microscopically it exists in two forms diffuse (mesenchymal) & desmoid.
  • The less common desmoid form rarely occurs in infancy.
  • The differential diagnosis of this type is infantile fibrosarcoma.
  • The tumor may locally recur if inadequately excised.
  • We report a case of infantile fibromatosis of desmoid type occurring in 10 months male child for its extreme rarity.
  • [MeSH-major] Fibromatosis, Aggressive / pathology. Neck Muscles / pathology. Soft Tissue Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16761760.001).
  • [ISSN] 0377-4929
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


52. Owens CL, Sharma R, Ali SZ: Deep fibromatosis (desmoid tumor): cytopathologic characteristics, clinicoradiologic features, and immunohistochemical findings on fine-needle aspiration. Cancer; 2007 Jun 25;111(3):166-72
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Deep fibromatosis (desmoid tumor): cytopathologic characteristics, clinicoradiologic features, and immunohistochemical findings on fine-needle aspiration.
  • BACKGROUND: Deep fibromatosis or desmoid tumor (DF/DT) is a low-grade, soft tissue lesion that is notable for its infiltration and local recurrence and its inability to metastasize.
  • METHODS: The surgical pathology files of The Johns Hopkins Hospital revealed 17 patients with a diagnosis of DF/DT with prior cytology in a 16-year period (1989-2005).
  • In patients with archived tissue, an immunohistochemical panel was performed that included beta-catenin, desmin, CD-34, and c-kit.
  • Predominantly bland spindled cells with long, fusiform nuclei and metachromatic matrix material were present in most tumors.
  • The tumor cells were present both singly and as fragments embedded in the matrix.
  • Nine patients had paraffin-embedded tissue samples available for immunohistochemical staining.
  • [MeSH-major] Fibromatosis, Aggressive / metabolism. Fibromatosis, Aggressive / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Antigens, CD34 / analysis. Biopsy, Fine-Needle. Child. Desmin / analysis. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Male. Middle Aged. Proto-Oncogene Proteins c-kit / analysis. beta Catenin / analysis

  • Genetic Alliance. consumer health - Desmoid Tumor.
  • Genetic Alliance. consumer health - Fibromatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17477374.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD34; 0 / Desmin; 0 / beta Catenin; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit
  •  go-up   go-down


53. Liu QY, Chen JY, Liang BL, Li HG, Gao M, Lin XF: [Imaging manifestations and pathologic features of soft tissue desmoid-type fibromatosis]. Ai Zheng; 2008 Dec;27(12):1287-92
MedlinePlus Health Information. consumer health - MRI Scans.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Imaging manifestations and pathologic features of soft tissue desmoid-type fibromatosis].
  • BACKGROUND & OBJECTIVE: Soft tissue desmoid-type fibromatosis is a type of benign, infiltrative tumors which are rarely seen.
  • This study was to analyze CT and MR manifestations and pathologic features of soft tissue desmoid-type fibromatosis to improve its diagnostic accuracy.
  • METHODS: A total of 34 soft tissue desmoid-type fibromatosis from 29 patients, including 20 primary and 14 recurrent tumors were analyzed.
  • Features of the growth pattern, CT or MRI findings and pathologic appearances of the tumors were studied.
  • RESULTS: The mean size of the 34 tumors was 6.5 cm.
  • Of the 34 tumors, 31(91.2%) had an ill-defined or partially ill-defined margin, 31(91.2%) had a lobulated or irregular contour, 17(50.0%) had neurovascular involvement, 15(44.1%) had bone involvement, 23(67.6%) had extra-compartmental extension.
  • Among the eight tumors scanned by CT, six showed slight hypodensity on the non-enhanced CT scan, and seven were inhomogeneously enhanced after contrast injection.
  • Twenty-six tumors scanned by MRI appeared either iso-or slightly hyperintense on T1W images, hyperintense on T2W images, and moderate or intense enhancement after gadolinium administration.
  • Heterogeneous signal intensity was detected in 88.5%(23/26) tumors.
  • Linear and curvilinear areas of signal void interspersed throughout the tumors were found in 22 tumors(84.6%) on both T1W and T2W images.
  • Histologic analysis revealed that the tumor was composed of spindle cells and collagen bundles, with a variable amount of intermingled collagen surrounding the spindle cells.
  • Nuclear atypia was not seen,and occasional mitoses were present in the tumor cells.
  • CONCLUSION: The characteristic manifestations of CT or MR images of desmoid-type fibromatosis provide important evidence to discriminate benign and malignant soft tissue tumors.
  • [MeSH-major] Extremities / radiography. Fibromatosis, Aggressive / diagnosis. Magnetic Resonance Imaging / methods. Soft Tissue Neoplasms / diagnosis. Tomography, X-Ray Computed / methods
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Child, Preschool. Female. Humans. Image Enhancement. Infant. Male. Middle Aged. Neoplasm Recurrence, Local. Retrospective Studies. Thoracic Wall / pathology. Thoracic Wall / radiography. Young Adult

  • Genetic Alliance. consumer health - Fibromatosis.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19079995.001).
  • [Journal-full-title] Ai zheng = Aizheng = Chinese journal of cancer
  • [ISO-abbreviation] Ai Zheng
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


54. Mankin HJ, Hornicek FJ, Springfield DS: Extra-abdominal desmoid tumors: a report of 234 cases. J Surg Oncol; 2010 Oct 1;102(5):380-4
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extra-abdominal desmoid tumors: a report of 234 cases.
  • BACKGROUND/OBJECTIVES: To report on the clinical presentation and outcome for 234 patients with extra-abdominal desmoids tumors.
  • METHODS: Since 1977, the authors have treated 234 patients with extra-abdominal desmoid tumors.
  • The tumors arose adjacent to muscles or bones and the largest number were in the foot, shoulder thigh and calf.
  • None of the patients died of disease but 5 required amputations.
  • CONCLUSIONS: The authors concluded that despite the benign nature of the disease, these patients are difficult to treat and the results are sometimes considerably less than optimal.
  • [MeSH-major] Fibromatosis, Abdominal / surgery. Fibromatosis, Aggressive / surgery. Neoplasm Recurrence, Local / surgery. Neoplasms, Multiple Primary / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] J. Surg. Oncol. 2010;102:380-384. © 2009 Wiley-Liss, Inc.
  • (PMID = 19877160.001).
  • [ISSN] 1096-9098
  • [Journal-full-title] Journal of surgical oncology
  • [ISO-abbreviation] J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


55. Montagliani L, Duverger V: [Desmoid tumors]. J Chir (Paris); 2008 Jan-Feb;145(1):20-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Desmoid tumors].
  • Desmoid tumors are a rare form of malignancy with a great propensity for local extension and recurrence.
  • They typically occur in the abdominal wall or within the abdomen but also may occur extra-abdominally.
  • [MeSH-major] Fibromatosis, Abdominal / surgery. Fibromatosis, Aggressive / surgery. Mesentery. Peritoneal Neoplasms / surgery
  • [MeSH-minor] Algorithms. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Chemotherapy, Adjuvant. Evidence-Based Medicine. Humans. Neoplasm Recurrence, Local / surgery. Prognosis. Radiotherapy, Adjuvant. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18438278.001).
  • [ISSN] 0021-7697
  • [Journal-full-title] Journal de chirurgie
  • [ISO-abbreviation] J Chir (Paris)
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 29
  •  go-up   go-down


56. Nieuwenhuis MH, Hartgrink HH, Meijer S, Menko FH, Vasen HF: [Desmoid tumour as indication of familial adenomatous polyposis]. Ned Tijdschr Geneeskd; 2010;154:A2235
Genetic Alliance. consumer health - Familial Polyposis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Desmoid tumour as indication of familial adenomatous polyposis].
  • In two patients, a man aged 43 and a woman aged 40 years, who presented with a desmoid tumour, familial adenomatous polyposis (FAP) was diagnosed three and six years later, respectively.
  • Desmoid-type fibromatoses usually develop sporadically, but may also be an extracolonic manifestation of FAP.
  • All patients with desmoids diagnosed who are under age 60, or with desmoids located intra-abdominally or in the abdominal wall, should be referred for colonic and genetic evaluation.
  • In all further patients with a desmoid tumour, the possibility of FAP should be considered and patient data and the family history should be evaluated thoroughly.
  • [MeSH-major] Adenomatous Polyposis Coli / diagnosis. Adenomatous Polyposis Coli / pathology. Fibromatosis, Aggressive / diagnosis. Fibromatosis, Aggressive / pathology
  • [MeSH-minor] Adult. Colonic Neoplasms / diagnosis. Colonic Neoplasms / secondary. Colonic Neoplasms / surgery. Female. Genes, APC. Genetic Predisposition to Disease. Humans. Male. Mutation. Neoplasm Metastasis. Rectal Neoplasms / diagnosis. Rectal Neoplasms / secondary. Rectal Neoplasms / surgery

  • Genetic Alliance. consumer health - Familial Adenomatous Polyposis (FAP).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20977806.001).
  • [ISSN] 1876-8784
  • [Journal-full-title] Nederlands tijdschrift voor geneeskunde
  • [ISO-abbreviation] Ned Tijdschr Geneeskd
  • [Language] dut
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


57. Dafford K, Kim D, Nelson A, Kline D: Extraabdominal desmoid tumors. Neurosurg Focus; 2007;22(6):E21

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extraabdominal desmoid tumors.
  • OBJECT: Desmoid tumors are fibrous, slow-growing, nonmalignant tumors with a low potential for metastasis.
  • METHODS: The authors undertook a retrospective study of 15 desmoid tumors in 11 women and four men (ranging in age from 32 to 67 years; median 48 years) treated at their institution.
  • This study included further resection for recurrent tumors in nine of 15 patients (60%).
  • There was tumor recurrence in two patients (13%) leading to further surgical intervention.
  • CONCLUSIONS: This case series included many recurrent desmoid tumors of the brachial plexus.
  • Most of these lesions were relatively large tumors, predominantly involved with the plexal elements adding to the challenge of the resection.
  • Currently, function-sparing excision is considered the optimal treatment for desmoid tumors arising in extraabdominal sites.
  • Adjunctive radiation or brachytherapy is reserved for a patient with further recurrence in whom resection would be disfiguring or in whom the disease is more refractory.
  • [MeSH-major] Fibromatosis, Abdominal / diagnosis. Fibromatosis, Abdominal / surgery
  • [MeSH-minor] Adult. Aged. Female. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Neoplasm Recurrence, Local / diagnosis. Neoplasm Recurrence, Local / pathology. Neoplasm Recurrence, Local / surgery. Postoperative Complications / diagnosis. Postoperative Complications / pathology. Postoperative Complications / surgery. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17613213.001).
  • [ISSN] 1092-0684
  • [Journal-full-title] Neurosurgical focus
  • [ISO-abbreviation] Neurosurg Focus
  • [Language] eng
  • [Publication-type] Case Reports; Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


58. Kitazawa S, Kitazawa R, Obayashi C, Yamamoto T: Desmoid tumor with ossification in chest wall: possible involvement of BAMBI promoter hypermethylation in metaplastic bone formation. J Bone Miner Res; 2005 Aug;20(8):1472-7
Genetic Alliance. consumer health - Desmoid Tumor.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoid tumor with ossification in chest wall: possible involvement of BAMBI promoter hypermethylation in metaplastic bone formation.
  • A rare case of desmoid-type fibromatosis with focal metaplastic bone in the chest wall suggested that enhanced responsiveness to BMP signaling by decreasing BAMBI expression through promoter hypermethylation plays a crucial role in the formation of metaplastic bone.
  • INTRODUCTION: Desmoid-type fibromatosis, originating from mesenchymal cells with myofibroblastic features, is a locally aggressive and frequently recurring infiltrative lesion.
  • RESULTS: Accumulation of altered beta-catenin associated with a somatic heterozygous activating mutation in codon 41 was detected in the typical desmoid-type fibromatosis and at the ossifying focus.
  • Hypermethylation of the BAMBI promoter was observed in microdissected tissue from the ossifying focus but not in that from the typical desmoid-type fibromatosis.
  • [MeSH-major] DNA Methylation. Fibromatosis, Aggressive / pathology. Membrane Proteins / genetics. Ossification, Heterotopic / genetics. Thoracic Wall

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16007344.001).
  • [ISSN] 0884-0431
  • [Journal-full-title] Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
  • [ISO-abbreviation] J. Bone Miner. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / BAMBI protein, human; 0 / BMP2 protein, human; 0 / Bone Morphogenetic Protein 2; 0 / Bone Morphogenetic Proteins; 0 / Membrane Proteins; 0 / Transforming Growth Factor beta
  •  go-up   go-down


59. Lanckohr C, Debiec-Rychter M, Müller O, Homann HH, Lehnhardt M, Herter P, Kuhnen C: [Gardner fibroma: case report and discussion of a new soft tissue tumor entity]. Pathologe; 2010 Mar;31(2):97-105

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Gardner fibroma: case report and discussion of a new soft tissue tumor entity].
  • Gardner fibroma represents a rare and recently described soft tissue tumor entity in children and young adults.
  • The case of a 13-year-old male patient with Gardner fibroma and osteoma and multicentric desmoid type fibromatosis in his mother is presented with detection of a (heterozygotic) germline mutation of the APC gene leading to a de novo stop codon (deletion of base pairs 5033-5036).
  • FISH analysis revealed a structural loss of heterozygosity (LOH) in the APC gene on chromosomal locus 5q21 in one out of five analysed desmoids of the mother, no LOH of APC gene in the Gardner fibroma.
  • Gardner fibroma in children and young adults may serve as an indicator lesion for familial adenomatous polyposis (FAP), Gardner syndrome, a familial desmoid type fibromatosis without other manifestations of APC or a new APC gene mutation.
  • For the clinician, this diagnosis should be commented upon accordingly by the surgical pathologist.
  • As the result of a detected APC gene mutation, continuous follow-up for the development of colorectal tumors and desmoid type fibromatosis as well as a familial screening for FAP is recommended.
  • [MeSH-major] Fibromatosis, Aggressive / genetics. Fibromatosis, Aggressive / pathology. Gardner Syndrome / genetics. Gardner Syndrome / pathology. Genes, APC. Germ-Line Mutation / genetics. Loss of Heterozygosity. Osteoma / genetics. Osteoma / pathology. Soft Tissue Neoplasms / genetics. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Biomarkers, Tumor / genetics. Breast Neoplasms / genetics. Breast Neoplasms / pathology. Chromosome Deletion. Chromosomes, Human, Pair 5 / genetics. Codon, Terminator / genetics. DNA Mutational Analysis. Female. Follow-Up Studies. Heterozygote Detection. Humans. In Situ Hybridization, Fluorescence. Male. Neoplasm Recurrence, Local / genetics. Neoplasm Recurrence, Local / pathology. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20063100.001).
  • [ISSN] 1432-1963
  • [Journal-full-title] Der Pathologe
  • [ISO-abbreviation] Pathologe
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Codon, Terminator
  •  go-up   go-down


60. Sakorafas GH, Nissotakis C, Peros G: Abdominal desmoid tumors. Surg Oncol; 2007 Aug;16(2):131-42

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Abdominal desmoid tumors.
  • Desmoid tumors are rare, benign, fibromatous lesions that are the result of abnormal proliferation of myofibroblasts.
  • Desmoid tumors can be classified as extra-abdominal and abdominal.
  • Abdominal desmoid tumors are either superficial or intraabdominal.
  • These tumors are associated with a high recurrence rates, even if their microscopic characters indicate a benign disease; their biologic behavior often indicates rather a "malignant" disease, which can cause even the death.
  • Intraabdominal desmoid tumors can engulf surrounding viscera and vessels, thereby greatly complicating their surgical treatment.
  • Simple observation is a reasonable management option for asymptomatic patients; spontaneous regression of these tumors may be observed.
  • Complete excision is the treatment of choice for tumors causing symptoms or complications.
  • [MeSH-major] Abdominal Neoplasms / pathology. Abdominal Neoplasms / therapy. Fibromatosis, Aggressive / pathology. Fibromatosis, Aggressive / therapy
  • [MeSH-minor] Algorithms. Diagnosis, Differential. Diagnostic Imaging. Genetic Testing. Humans. Medical History Taking

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17719772.001).
  • [ISSN] 0960-7404
  • [Journal-full-title] Surgical oncology
  • [ISO-abbreviation] Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 86
  •  go-up   go-down


61. Hauben EI, Jundt G, Cleton-Jansen AM, Yavas A, Kroon HM, Van Marck E, Hogendoorn PC: Desmoplastic fibroma of bone: an immunohistochemical study including beta-catenin expression and mutational analysis for beta-catenin. Hum Pathol; 2005 Sep;36(9):1025-30
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoplastic fibroma of bone: an immunohistochemical study including beta-catenin expression and mutational analysis for beta-catenin.
  • Desmoplastic fibroma of bone is a very rare primary bone tumor morphologically resembling desmoid-type fibromatosis, its much more common counterpart of soft tissue.
  • The aim of this study is to investigate the immunohistochemical profile and the involvement of the beta-catenin pathway in desmoplastic fibroma as it is known in desmoid-type fibromatosis.
  • Immunohistochemistry was performed on 13 cases of desmoplastic fibroma for muscle-specific markers, estrogen and progesterone receptors, CD117, beta-catenin, and the potential downstream target of beta-catenin, namely, cyclin D1.
  • The epidemiological, histological, and immunohistochemical findings in desmoplastic fibroma are suggestive of desmoplastic fibroma being the bony counterpart of the more common desmoid-type fibromatosis of soft tissue.
  • However, the beta-catenin pathway does not seem to have the same essential role in the tumorigenesis of desmoplastic fibroma, as it has in desmoid-type fibromatosis.
  • [MeSH-major] Bone Neoplasms / metabolism. Cytoskeletal Proteins / genetics. Cytoskeletal Proteins / metabolism. Fibroma, Desmoplastic / metabolism. Trans-Activators / genetics. Trans-Activators / metabolism

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16153468.001).
  • [ISSN] 0046-8177
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CTNNB1 protein, human; 0 / Cytoskeletal Proteins; 0 / Trans-Activators; 0 / beta Catenin
  •  go-up   go-down


62. Tamura K, Tani M, Kinoshita H, Yamaue H: Mesenteric desmoid tumor of the interposed jejunal pouch after total gastrectomy. World J Surg Oncol; 2006;4:27

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mesenteric desmoid tumor of the interposed jejunal pouch after total gastrectomy.
  • BACKGROUND: Desmoid tumor is a rare entity, and most desmoid tumors are located in abdominal wall or extra-abdominal tissues.
  • Occurrence of desmoid tumor in mesentry is extremely rare.
  • CASE PRESENTATION: we report a mesenteric desmoid tumor in a 73-years-old woman who had undergone total gastrectomy reconstructed with jejunal pouch interposition for gastric carcinoma.
  • After 1 year, a tumor was originating from mesentery of the interposed jejunal pouch was identified, and the patient underwent resection of the large mass which was found to invade pancreas.
  • Histological examination revealed desmoid tumor.
  • CONCLUSION: Desmoid tumor is rare, and it was difficult for the differential diagnosis of desmoid tumor or recurrent tumor.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 1999 Jan;17(1):158-67 [10458229.001]
  • [Cites] Gut. 2001 Apr;48(4):515-21 [11247896.001]
  • [Cites] Cancer. 2004 Feb 1;100(3):612-20 [14745880.001]
  • [Cites] Arch Surg. 1979 Oct;114(10):1181-5 [158353.001]
  • [Cites] J Clin Oncol. 2006 Jan 1;24(1):11-2 [16330666.001]
  • [Cites] Br J Surg. 1996 Nov;83(11):1494-504 [9014661.001]
  • [Cites] Arch Surg. 1991 Dec;126(12):1469-73 [1842175.001]
  • [Cites] Ann Surg. 1989 Dec;210(6):765-9 [2531573.001]
  • [Cites] Eur J Cancer Clin Oncol. 1986 May;22(5):583-7 [3770030.001]
  • [Cites] Am J Clin Pathol. 1982 Jun;77(6):665-73 [7091046.001]
  • [Cites] Cancer. 1994 Aug 15;74(4):1270-4 [7519966.001]
  • [Cites] World J Surg Oncol. 2006;4:21 [16584569.001]
  • (PMID = 16740152.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1481628
  •  go-up   go-down


63. González MA, Menéndez R, Ayala JM, Herrero M, Cuesta J, Domínguez A, Martínez M, Graña JL, Pozo F: [Intra-abdominal desmoid tumor]. Cir Esp; 2005 Jun;77(6):362-4
Genetic Alliance. consumer health - Desmoid Tumor.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intra-abdominal desmoid tumor].
  • [Transliterated title] Tumor desmoide intraabdominal.
  • Aggressive fibromatosis (desmoid tumor) are rare connective tissue tumors that occur sporadically or in association with familial adenomatous polyposis.
  • Biopsy is required to establish the diagnosis.
  • [MeSH-major] Fibromatosis, Aggressive / pathology. Fibromatosis, Aggressive / surgery. Retroperitoneal Neoplasms / pathology. Retroperitoneal Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16420952.001).
  • [ISSN] 0009-739X
  • [Journal-full-title] Cirugía española
  • [ISO-abbreviation] Cir Esp
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


64. Hosalkar HS, Torbert JT, Fox EJ, Delaney TF, Aboulafia AJ, Lackman RD: Musculoskeletal desmoid tumors. J Am Acad Orthop Surg; 2008 Apr;16(4):188-98

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Musculoskeletal desmoid tumors.
  • Desmoid tumors are benign tumors that exhibit varying degrees of local aggressiveness and diverse growth patterns.
  • Magnetic resonance imaging remains the modality of choice for assessment of the nature and size of the soft-tissue lesion and involvement of surrounding structures.
  • Despite the benign nature of these tumors, multidisciplinary care is needed to provide combined treatment options.
  • Chemotherapy in low doses is an excellent first-round treatment in any patient in whom contemplated local treatment may produce local morbidity and adjacent tissue injury.
  • [MeSH-major] Fibromatosis, Aggressive. Muscle Neoplasms
  • [MeSH-minor] Humans. Soft Tissue Neoplasms / diagnosis. Soft Tissue Neoplasms / pathology. Soft Tissue Neoplasms / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18390481.001).
  • [ISSN] 1067-151X
  • [Journal-full-title] The Journal of the American Academy of Orthopaedic Surgeons
  • [ISO-abbreviation] J Am Acad Orthop Surg
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 65
  •  go-up   go-down


65. Tkachev SI, Aliev MD, Glebovskaia VV, Ivanov SM, Trofimova OP, Karapetian RM, Gutnik RA, Bokhian AIu: [Thermoradiotherapy as a component of desmoid tumor management: 10-year experience]. Vopr Onkol; 2005;51(3):347-9
Genetic Alliance. consumer health - Desmoid Tumor.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Thermoradiotherapy as a component of desmoid tumor management: 10-year experience].
  • Data on radio- and thermoradiotherapy of 83 patients with extra-abdominal desmoid tumors are discussed.
  • Monitoring tumor temperature during local hyperthermia is a factor of relapse-free survival of vital importance.
  • [MeSH-major] Fibromatosis, Aggressive / radiotherapy. Hyperthermia, Induced
  • [MeSH-minor] Disease-Free Survival. Follow-Up Studies. Humans. Radiotherapy / methods. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16279100.001).
  • [ISSN] 0507-3758
  • [Journal-full-title] Voprosy onkologii
  • [ISO-abbreviation] Vopr Onkol
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


66. Fiore M, Rimareix F, Mariani L, Domont J, Collini P, Le Péchoux C, Casali PG, Le Cesne A, Gronchi A, Bonvalot S: Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment. Ann Surg Oncol; 2009 Sep;16(9):2587-93
Genetic Alliance. consumer health - Fibromatosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment.
  • PURPOSE: Surgery is still the standard treatment for desmoid-type fibromatosis (DF).
  • The disease remained stable in more than half of patients.
  • This study was designed to evaluate this approach on the natural history of the disease in a larger series of patients.
  • RESULTS: Seventy-four patients presented with primary tumor, 68 with recurrence.
  • Half of patients had medium-term stable disease after W&S or MT.
  • [MeSH-major] Fibromatosis, Aggressive / pathology. Fibromatosis, Aggressive / surgery. Neoplasm Recurrence, Local / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19568815.001).
  • [ISSN] 1534-4681
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


67. Okuno S: The enigma of desmoid tumors. Curr Treat Options Oncol; 2006 Nov;7(6):438-43
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The enigma of desmoid tumors.
  • Desmoid tumors (aggressive fibromatosis) are rare neoplastic tumors that may occur sporadically or in association with familial adenomatous polyposis (FAP).
  • The etiology of these tumors is unknown, but hormonal, genetic, and physical factors play a role in their development and growth.
  • A distinction is often made between desmoids in patients with FAP and those in patients without FAP, but clinically these tumors are treated the same; the only difference is the preferential intra-abdominal location of FAP desmoids.
  • The goal of desmoid treatment is local control.
  • In addition, because desmoids spontaneously regress, any claim of successful intervention must be viewed skeptically.
  • Patients with symptomatic, progressive disease who can tolerate chemotherapy should be presented with the option of low-dose or standard antisarcoma chemotherapy.
  • The treatment of desmoid tumors remains an enigma.
  • Further clinical trials are needed to help the clinician navigate his or her way through the morass of desmoid tumor therapies.
  • [MeSH-major] Fibromatosis, Abdominal / diagnosis. Fibromatosis, Abdominal / drug therapy

  • Hazardous Substances Data Bank. TAMOXIFEN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17032556.001).
  • [ISSN] 1527-2729
  • [Journal-full-title] Current treatment options in oncology
  • [ISO-abbreviation] Curr Treat Options Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents, Non-Steroidal; 094ZI81Y45 / Tamoxifen; 9008-11-1 / Interferons
  • [Number-of-references] 22
  •  go-up   go-down


68. Lath C, Khanna PC, Gadewar SB, Agrawal D: Inoperable aggressive mesenteric fibromatosis with ureteric fistula. Case report and literature review. Eur J Radiol; 2006 Jul;59(1):117-21
MedlinePlus Health Information. consumer health - Ureteral Disorders.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inoperable aggressive mesenteric fibromatosis with ureteric fistula. Case report and literature review.
  • The purpose of our report is to illustrate an aggressive case of mesenteric fibromatosis in a 17-year-old girl with a ureteric fistula and to review imaging and pathological features, natural history and treatment options of this disease.
  • Our patient underwent computed tomography that revealed a widespread intra-abdominal mass.
  • Fibromatoses represent a spectrum of uncommon benign conditions characterised by proliferating fibrous tissue.
  • The deep intra-abdominal form of mesenteric fibromatosis (MF), one of the rare subtypes of the 'fibromatoses' or 'desmoid tumours', grows rapidly and may become extensive.
  • Surgery provides good results in limited disease and non-surgical modalities in cases of unresectable and residual disease.
  • [MeSH-major] Fibromatosis, Abdominal / radiography. Fibromatosis, Aggressive / radiography. Mesentery / pathology. Tomography, X-Ray Computed. Ureteral Diseases / radiography. Urinary Fistula / radiography

  • Genetic Alliance. consumer health - Aggressive Fibromatosis.
  • Genetic Alliance. consumer health - Fibromatosis.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Eur J Radiol. 2006 Dec;60(3):480
  • (PMID = 16464556.001).
  • [ISSN] 0720-048X
  • [Journal-full-title] European journal of radiology
  • [ISO-abbreviation] Eur J Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Ireland
  • [Number-of-references] 16
  •  go-up   go-down


69. Bölke E, Krasniqi H, Lammering G, Engers R, Matuschek C, Gripp S, Gerber PA, Fischer G, Peiper M, Shaikh S, Budach W, Orth K: Chest wall and intrathoracic desmoid tumors: surgical experience and review of the literature. Eur J Med Res; 2009 Jun 18;14(6):240-3

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chest wall and intrathoracic desmoid tumors: surgical experience and review of the literature.
  • Desmoid tumors are fibroblastic/myofibroblastic neoplasms, which originate from musculo-aponeurotic structures and are classified as deep fibromatoses.
  • Despite their benign histologic appearance and lack of metastatic potential, desmoid tumors may cause aggres?sive local infiltrations and compression of surrounding structures.
  • Molecular studies have demonstrated that these patients are associated with a bi-allelic APC mutation in the affected tissue.
  • Radical tumor resection with free margins remains the first therapy of choice.
  • [MeSH-major] Fibromatosis, Abdominal / pathology. Fibromatosis, Aggressive / pathology. Thoracic Neoplasms / pathology. Thoracic Wall / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 2000 Apr 1;88(7):1517-23 [10738207.001]
  • [Cites] J Thorac Oncol. 2008 Jun;3(6):656-9 [18520808.001]
  • [Cites] Br J Surg. 2002 Dec;89(12):1563-9 [12445067.001]
  • [Cites] Ann Thorac Surg. 2004 Oct;78(4):1219-23; discussion 1219-23 [15464474.001]
  • [Cites] Br J Surg. 1971 Jul;58(7):495-8 [4253594.001]
  • [Cites] S Afr J Surg. 1971 Jul-Sep;9(3):133-40 [5138518.001]
  • [Cites] J Thorac Cardiovasc Surg. 1985 Sep;90(3):367-72 [4033174.001]
  • [Cites] Am J Med Genet. 1987 Oct;28(2):385-92 [2827474.001]
  • [Cites] Am J Surg. 1990 May;159(5):450-3 [2139764.001]
  • [Cites] Hum Mol Genet. 1995 Mar;4(3):337-40 [7795585.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1997 Oct 1;39(3):659-65 [9336146.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1998 Dec 1;42(5):1007-14 [9869223.001]
  • [Cites] Semin Thorac Cardiovasc Surg. 1999 Jul;11(3):264-9 [10451258.001]
  • [Cites] J Clin Oncol. 1999 Jan;17(1):158-67 [10458229.001]
  • [Cites] Gut. 2004 Dec;53(12):1832-6 [15542524.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):882-91 [15708271.001]
  • [Cites] Dis Colon Rectum. 2005 Jun;48(6):1275-81 [15793634.001]
  • [Cites] AJR Am J Roentgenol. 2006 Jan;186(1):247-54 [16357411.001]
  • [Cites] Histol Histopathol. 2008 Jan;23(1):117-26 [17952864.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):441-7 [18068311.001]
  • [Cites] Eur J Surg Oncol. 2001 Dec;27(8):701-6 [11735163.001]
  • (PMID = 19541583.001).
  • [ISSN] 0949-2321
  • [Journal-full-title] European journal of medical research
  • [ISO-abbreviation] Eur. J. Med. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 31
  • [Other-IDs] NLM/ PMC3352015
  •  go-up   go-down


70. Leal RF, Silva PV, Ayrizono Mde L, Fagundes JJ, Amstalden EM, Coy CS: Desmoid tumor in patients with familial adenomatous polyposis. Arq Gastroenterol; 2010 Oct-Dec;47(4):373-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoid tumor in patients with familial adenomatous polyposis.
  • CONTEXT: Desmoid tumors constitute one of the most important extraintestinal manifestations of familial adenomatous polyposis.
  • The development of desmoids is responsible for increasing morbidity and mortality rates in cases of familial adenomatous polyposis.
  • OBJECTIVES: To evaluate the occurrence of desmoid tumors in familial adenomatous polyposis cases following prophylactic colectomy and to present patient outcome.
  • Desmoid tumors were found in nine (13.2%) of these patients, who were studied retrospectively by consulting their medical charts with respect to clinical and surgical data.
  • RESULTS: Of nine patients, seven (77.8%) were submitted to laparotomy for tumor resection.
  • Desmoid tumors were found in the abdominal wall in 3/9 cases (33.3%) and in an intra-abdominal site in the remaining six cases (66.7%).
  • Median time elapsed between ileal pouch-anal anastomosis and diagnosis of desmoid tumor was 37.5 months (range 14-60 months), while the median time between colectomy with ileorectal anastomosis and diagnosis was 63.7 months (range 25-116 months).
  • In 6/9 (66.7%) patients with desmoid tumors, the disease was either under control or there was no evidence of tumor recurrence at a follow-up visit made a mean of 63.1 months later (range 12-240 months).
  • CONCLUSIONS: Desmoid tumors were found in 13.2% of cases of familial adenomatous polyposis following colectomy; therefore, familial adenomatous polyposis patients should be followed-up and surveillance should include abdominal examination to detect signs and symptoms.
  • [MeSH-major] Abdominal Neoplasms / surgery. Colectomy. Fibromatosis, Abdominal / surgery. Fibromatosis, Aggressive / surgery
  • [MeSH-minor] Abdominal Wall / surgery. Adult. Anastomosis, Surgical. Female. Follow-Up Studies. Humans. Male. Middle Aged. Treatment Outcome. Young Adult


71. Oddsson SJ, Kristvinsson H, Jónsson JG, Torfason B, Gudbjartsson T: [Desmoid tumor of chest wall--an important differential diagnosis to malignancies]. Laeknabladid; 2006 Nov;92(11):777-80
Genetic Alliance. consumer health - Desmoid Tumor.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Desmoid tumor of chest wall--an important differential diagnosis to malignancies].
  • [Transliterated title] Desmoid-aexli í brjóstvegg--mikilvaeg mismunagreining vieth illkynja mein.
  • Desmoid tumors are rare solid tumors that arise from musculoaponeurotic tissues.
  • They are classified as benign as they do not metastasize.
  • Desmoid tumors can, however, exhibit rapid local growth and clinically they can mimic sarcomas.
  • Their histological appearance can also resemble some malignant neoplasms such as low grade sarcomas, rendering the differential diagnosis difficult.
  • The tumor increased in size over several weeks and caused local radiating chest pain.
  • Open biopsy revealed a desmoid tumor.
  • The tumor was resected together with a part of the anterior hemithorax, and the defect in the chest wall covered with a Goretex-patch.
  • Six months postoperatively, the patient is doing well with no signs of locally recurrent disease.
  • [MeSH-major] Fibromatosis, Aggressive / diagnosis. Thoracic Neoplasms / diagnosis. Thoracic Wall / pathology
  • [MeSH-minor] Diagnosis, Differential. Female. Humans. Middle Aged. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17093329.001).
  • [ISSN] 0023-7213
  • [Journal-full-title] Læknablađiđ
  • [ISO-abbreviation] Laeknabladid
  • [Language] ice
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Iceland
  •  go-up   go-down


72. Jalini L, Hemming D, Bhattacharya V: Intraabdominal desmoid tumour presenting with perforation. Surgeon; 2006 Apr;4(2):114-6

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intraabdominal desmoid tumour presenting with perforation.
  • We present a rare case of a desmoid tumour presenting with perforation of the small bowel.
  • Although desmoid is classified pathologically as a benign tumour, its infiltrative nature leads to a locally aggressive mass, which can invade surrounding structures and organs making surgical resection difficult.
  • Some unresectable tumours show oestrogen receptor positive cells and can be managed with tamoxifen.
  • [MeSH-major] Fibromatosis, Abdominal / pathology. Intestinal Perforation / etiology. Intestine, Small. Mesentery. Peritoneal Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16623170.001).
  • [ISSN] 1479-666X
  • [Journal-full-title] The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland
  • [ISO-abbreviation] Surgeon
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


73. Chummun S, McLean NR, Abraham S, Youseff M: Desmoid tumour of the breast. J Plast Reconstr Aesthet Surg; 2010 Feb;63(2):339-45
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoid tumour of the breast.
  • Desmoid tumour of the breast is a rare fibroblastic tumour whose spectrum ranges from being locally inert to aggressive and destructive, and represents 0.2% of all breast tumours.
  • Ultrasound showed a well-defined, hypoechoic mass arising within the muscles of the anterior chest, deep beneath the implant and not involving the underlying rib.
  • A provisional diagnosis of scarring and fibroblastic proliferation was made.
  • A final diagnosis of aggressive fibromatosis was made.
  • Although the association of desmoid tumour and breast implants has been described, this case is unique as the FNA was highly suggestive of a silicone granuloma and the diagnosis of desmoid tumour was made on definitive pathology.
  • The aetiology of desmoid tumours is reviewed and current treatment modalities discussed.
  • [MeSH-major] Breast Neoplasms / diagnosis. Breast Neoplasms / surgery. Fibromatosis, Aggressive / diagnosis. Fibromatosis, Aggressive / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] 2008 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 19059821.001).
  • [ISSN] 1878-0539
  • [Journal-full-title] Journal of plastic, reconstructive & aesthetic surgery : JPRAS
  • [ISO-abbreviation] J Plast Reconstr Aesthet Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


74. Sturt NJ, Clark SK: Current ideas in desmoid tumours. Fam Cancer; 2006;5(3):275-85; discussion 287-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Current ideas in desmoid tumours.
  • Desmoid tumours are rare neoplasms of fibroblastic origin which arise with disproportionate frequency in patients with familial adenomatous polyposis (FAP).
  • Risk factors include trauma, having a distal germline APC mutation, having a family history of desmoids, and probably oestrogens.
  • Desmoids are now known to be true neoplasms but with normal telomere length and telomerase activity.
  • FAP-associated tumours seem to carry biallelic APC mutations, one of which lies in the distal part of the gene.
  • Such loss of wild-type APC seems to occur relatively late in tumour development.
  • FAP-associated desmoids tend to arise in the abdomen or abdominal wall.
  • CT scanning gives the best information on tumour anatomy whilst T2-weighted MRI indicates likely behaviour.
  • Cytotoxic chemotherapy is an option in unresectable tumours.
  • Surgery is a reasonable first-line treatment in abdominal wall tumours but is risky for intra-abdominal tumours and may necessitate massive small bowel resection.
  • Desmoids are the greatest remaining challenge in the management of FAP and further research into their aetiology needs to be combined with multicentre clinical trials of new treatments in order to improve management of the disease.
  • [MeSH-major] Adenomatous Polyposis Coli / complications. Fibromatosis, Abdominal / etiology. Fibromatosis, Aggressive / etiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16998673.001).
  • [ISSN] 1389-9600
  • [Journal-full-title] Familial cancer
  • [ISO-abbreviation] Fam. Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 68
  •  go-up   go-down


75. Tanaka K, Yoshikawa R, Yanagi H, Gega M, Fujiwara Y, Hashimoto-Tamaoki T, Hirota S, Tsujimura T, Tomita N: Regression of sporadic intra-abdominal desmoid tumour following administration of non-steroidal anti-inflammatory drug. World J Surg Oncol; 2008;6:17

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Regression of sporadic intra-abdominal desmoid tumour following administration of non-steroidal anti-inflammatory drug.
  • BACKGROUND: Desmoid tumours or fibromatoses are rare entities characterized by the benign proliferation of fibroblasts, which can be life-threatening due to their locally aggressive properties.
  • Surgery is widely accepted as the first line of treatment for extra-abdominal desmoids; however, it is not recommended for intra-abdominal desmoids because of the high-risk of recurrence and difficulties with the operation.
  • Here, we report on a patient with sporadic intra-abdominal desmoid tumours, who showed partial response following the intake of non-steroidal anti-inflammatory drugs.
  • Computed tomography showed an abnormal multilocular soft-tissue mass (95 x 70 mm) in the right pelvis, which was revealed by biopsy to be a desmoid tumour.
  • Immunohistochemical analysis showed that the tumour cells expressed vimentin, but not smooth-muscle actin, CD34, or desmin.
  • Two years after the commencement of non-steroidal anti-inflammatory drug administration, computed tomography showed a decrease in tumour size (63 x 49 mm), and the disappearance of intratumoural septa.
  • CONCLUSION: Our case report suggests that non-steroidal anti-inflammatory drug treatment should be taken into consideration for use as first-line treatment in patients with sporadic intra-abdominal desmoid tumours.
  • [MeSH-major] Abdominal Neoplasms / drug therapy. Anti-Inflammatory Agents, Non-Steroidal / therapeutic use. Fibromatosis, Abdominal / drug therapy. Fibromatosis, Aggressive / drug therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cell. 2000 Oct 13;103(2):311-20 [11057903.001]
  • [Cites] Oncogene. 2001 Jan 25;20(4):451-60 [11313976.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 May 14;99(10):6973-8 [11983872.001]
  • [Cites] Ann Oncol. 2003 Feb;14(2):181-90 [12562642.001]
  • [Cites] J Clin Oncol. 2006 Jan 1;24(1):102-5 [16382119.001]
  • [Cites] Cancer Res. 1993 Nov 1;53(21):5079-82 [8221638.001]
  • [Cites] Cell. 1996 Oct 18;87(2):159-70 [8861899.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Dec 20;102(51):18567-71 [16352713.001]
  • [Cites] Br J Cancer. 2004 Jan 12;90(1):224-9 [14710233.001]
  • (PMID = 18257933.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Anti-Inflammatory Agents, Non-Steroidal
  • [Other-IDs] NLM/ PMC2270274
  •  go-up   go-down


76. Kourda N, Ben Slama S, Mrabet N, Sayari S, Zouache A, Ben Jilani SB, Zermani R: [Abdominal desmoid tumor: pathologic and therapeutic concepts]. Tunis Med; 2008 Oct;86(10):916-20
Genetic Alliance. consumer health - Desmoid Tumor.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Abdominal desmoid tumor: pathologic and therapeutic concepts].
  • [Transliterated title] Tumeur desmoide abdominale: concepts histopathologiques et therapeutiques.
  • BACKGROUND: Abdominal desmoid tumors arise in young adults between 20 and 40 years.
  • METHODS: From 1990 to 2004, three cases of abdominal desmoid tumors were diagnosed in the Pathologic laboratory of the Charles Nicole Hospital of Tunis.
  • All the patients were operated and the size of tumours varied to 5 to 7cm.
  • CONCLUSION: Abdominal desmoid tumors are locally aggressive but never give metastasis.
  • [MeSH-major] Abdominal Neoplasms / pathology. Abdominal Neoplasms / therapy. Fibromatosis, Aggressive / pathology. Fibromatosis, Aggressive / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19472812.001).
  • [ISSN] 0041-4131
  • [Journal-full-title] La Tunisie médicale
  • [ISO-abbreviation] Tunis Med
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Tunisia
  •  go-up   go-down


77. Bonvalot S, Rimareix F, Causeret S, Le Péchoux C, Boulet B, Terrier P, Le Cesne A, Muret J: Hyperthermic isolated limb perfusion in locally advanced soft tissue sarcoma and progressive desmoid-type fibromatosis with TNF 1 mg and melphalan (T1-M HILP) is safe and efficient. Ann Surg Oncol; 2009 Dec;16(12):3350-7
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hyperthermic isolated limb perfusion in locally advanced soft tissue sarcoma and progressive desmoid-type fibromatosis with TNF 1 mg and melphalan (T1-M HILP) is safe and efficient.
  • BACKGROUND: In a prior randomized phase II trial comparing hyperthermic isolated limb perfusion (HILP) with four different doses of tumor necrosis factor alpha (TNF-alpha), no dose effect was detected for response, but systemic toxicity was far lower with low-dose TNF-alpha.
  • The objective of the present study was to confirm these data on a larger sample size of locally advanced or recurrent extremity soft tissue sarcomas with low-dose TNF-alpha.
  • The remnant tumor was resected 2 months later.
  • Tumor grades (FNCLCC) were 1 (23 patients), 2 (34 patients), and 3 (43 patients).
  • Age, sex, tumor size, recurrence, uni- or multifocality, grade, preoperative chemotherapy, and a previously irradiated field were not predictive of response or local toxicity.
  • [MeSH-major] Antineoplastic Agents, Alkylating / administration & dosage. Chemotherapy, Cancer, Regional Perfusion. Extremities / pathology. Fibromatosis, Aggressive / therapy. Hyperthermia, Induced. Melphalan / administration & dosage. Sarcoma / therapy. Tumor Necrosis Factor-alpha / administration & dosage
  • [MeSH-minor] Adolescent. Adult. Aged. Drug Therapy, Combination. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Staging. Prognosis. Prospective Studies. Survival Rate. Young Adult

  • Genetic Alliance. consumer health - Soft tissue sarcoma.
  • Genetic Alliance. consumer health - Fibromatosis.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • Hazardous Substances Data Bank. MELPHALAN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19830495.001).
  • [ISSN] 1534-4681
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Alkylating; 0 / Tumor Necrosis Factor-alpha; Q41OR9510P / Melphalan
  •  go-up   go-down


78. Ferenc T, Wroński JW, Kopczyński J, Kulig A, Sidor M, Stalińska L, Dziki A, Sygut J: Analysis of APC, alpha-, beta-catenins, and N-cadherin protein expression in aggressive fibromatosis (desmoid tumor). Pathol Res Pract; 2009;205(5):311-24
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Analysis of APC, alpha-, beta-catenins, and N-cadherin protein expression in aggressive fibromatosis (desmoid tumor).
  • The aims of this study were to analyze the cadherin/catenin adhesion complex in cells from abdominal and extra-abdominal aggressive fibromatosis tumors, and to estimate the correlation between the expression of the tested proteins and the clinical data of the desmoid patients.
  • Immunohistochemistry was used to examine the expression of the cadherin/catenin adhesion complex: APC protein, alpha-, beta-catenin, and N-cadherin in archival material derived from 15 cases of extra-abdominal desmoid tumor (E-AD) and 20 cases of abdominal (AD) desmoid tumor.
  • In the E-AD group, in both cases of recurrent tumors, no alpha-catenin expression was observed but the expression of this protein was detected in primary tumors.
  • In the groups investigated, no statistically significant correlation was found between alpha-catenin, beta-catenin (c), (n) and (c+n) expression, and tumor size (p>0.1).
  • The results regarding beta-catenin expression obtained in our study confirm the previous findings that nuclear accumulation of this protein plays a crucial role in the pathogenesis of aggressive fibromatosis.
  • [MeSH-major] Adenomatous Polyposis Coli Protein / biosynthesis. Cadherins / biosynthesis. Fibromatosis, Aggressive / metabolism. alpha Catenin / biosynthesis. beta Catenin / biosynthesis
  • [MeSH-minor] Adult. Age Factors. Aged. Biomarkers, Tumor / analysis. Female. Gene Expression. Humans. Immunohistochemistry. Male. Young Adult

  • Genetic Alliance. consumer health - Desmoid Tumor.
  • Genetic Alliance. consumer health - Aggressive Fibromatosis.
  • Genetic Alliance. consumer health - Fibromatosis.
  • Genetics Home Reference. consumer health - CTNNB1 gene.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19124205.001).
  • [ISSN] 1618-0631
  • [Journal-full-title] Pathology, research and practice
  • [ISO-abbreviation] Pathol. Res. Pract.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Adenomatous Polyposis Coli Protein; 0 / Biomarkers, Tumor; 0 / Cadherins; 0 / alpha Catenin; 0 / beta Catenin
  •  go-up   go-down


79. Rampone B, Pedrazzani C, Marrelli D, Pinto E, Roviello F: Updates on abdominal desmoid tumors. World J Gastroenterol; 2007 Dec 7;13(45):5985-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Updates on abdominal desmoid tumors.
  • Desmoid tumor is a monoclonal, fibroblastic proliferation arising in musculoaponeurotic structures.
  • This connective tissue hyperplasia infiltrates locally, recurs frequently after resection but does not metastasize.
  • Abdominal desmoid occurs sporadically, in association with some familial syndromes and often represents a clinical dilemma for surgeons.
  • The enigmatic biology and anatomical location of abdominal desmoids make treatment recommendations difficult.
  • [MeSH-major] Fibromatosis, Abdominal / therapy. Neoplasm Recurrence, Local

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18023087.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] China
  • [Number-of-references] 50
  • [Other-IDs] NLM/ PMC4250878
  •  go-up   go-down


80. Skapek SX, Ferguson WS, Granowetter L, Devidas M, Perez-Atayde AR, Dehner LP, Hoffer FA, Speights R, Gebhardt MC, Dahl GV, Grier HE, Pediatric Oncology Group: Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial. J Clin Oncol; 2007 Feb 10;25(5):501-6
Hazardous Substances Data Bank. VINBLASTINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial.
  • PURPOSE: To determine the efficacy and safety of using vinblastine (Vbl) and methotrexate (Mtx) in children with desmoid-type fibromatosis that is recurrent or not amenable to treatment with radiation or surgery.
  • Response was assessed by bidimensional measurements of tumor on axial imaging (magnetic resonance imaging or computed tomography).
  • A measurable response was documented in eight patients (31%), and 10 patients had stable disease documented as the best response to treatment.
  • Eighteen patients had disease progression at a median time of 9.1 months.
  • Eight patients remain free of disease progression at a median of 43.4 months from study entry.
  • CONCLUSION: Vbl and Mtx are well tolerated in children with desmoid-type fibromatosis.
  • Furthermore, this combination can promote tumor regression or block tumor growth in most children.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Fibromatosis, Aggressive / drug therapy
  • [MeSH-minor] Adolescent. Antimetabolites, Antineoplastic / administration & dosage. Antineoplastic Agents, Phytogenic / administration & dosage. Child. Child, Preschool. Disease-Free Survival. Drug Administration Schedule. Female. Humans. Infant. Injections, Intravenous. Kaplan-Meier Estimate. Male. Methotrexate / administration & dosage. Prospective Studies. Time Factors. Treatment Outcome. Vinblastine / administration & dosage

  • Genetic Alliance. consumer health - Fibromatosis.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. METHOTREXATE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17290057.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA098543-02; United States / NCI NIH HHS / CA / CA29139
  • [Publication-type] Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / Antineoplastic Agents, Phytogenic; 5V9KLZ54CY / Vinblastine; YL5FZ2Y5U1 / Methotrexate
  •  go-up   go-down


81. Hosalkar HS, Fox EJ, Delaney T, Torbert JT, Ogilvie CM, Lackman RD: Desmoid tumors and current status of management. Orthop Clin North Am; 2006 Jan;37(1):53-63

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoid tumors and current status of management.
  • Desmoid tumors, also known as aggressive fibromatosis, are rare fibroblastic tumors that exhibit a wide range of local aggressiveness, from largely indolent to locally destructive.
  • Understanding of the pathogenesis and the great heterogeneity in the natural history of desmoid tumors is invaluable to the development of therapeutic strategies.
  • The rarity of cases in even major tumor centers has traditionally limited the ability to study this disease.
  • [MeSH-major] Fibromatosis, Aggressive / pathology. Fibromatosis, Aggressive / therapy. Soft Tissue Neoplasms / pathology. Soft Tissue Neoplasms / therapy
  • [MeSH-minor] Adolescent. Adult. Biopsy, Needle. Chemotherapy, Adjuvant. Combined Modality Therapy / methods. Female. Humans. Immunohistochemistry. Magnetic Resonance Imaging / methods. Male. Middle Aged. Neoplasm Staging. Prognosis. Radiotherapy, Adjuvant. Risk Assessment. Survival Analysis. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16311111.001).
  • [ISSN] 0030-5898
  • [Journal-full-title] The Orthopedic clinics of North America
  • [ISO-abbreviation] Orthop. Clin. North Am.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 51
  •  go-up   go-down


82. Souza FF, Fennessy FM, Yang Q, van den Abbeele AD: Case report. PET/CT appearance of desmoid tumour of the chest wall. Br J Radiol; 2010 Feb;83(986):e39-42

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Case report. PET/CT appearance of desmoid tumour of the chest wall.
  • Desmoid tumours are rare, poorly circumscribed tumours that have a firm consistency and, although benign, have a remarkable tendency to infiltrate into surrounding structures.
  • Extra-abdominal desmoid tumours involve mainly the extremities or the chest wall and are usually managed by wide radical resection.
  • Moreover, desmoid tumours involving the chest wall are locally aggressive tumours with a high recurrence rate.
  • We report a case of a pathologically proven desmoid tumour of the chest wall in a patient with a history of bilateral breast cancer and oesophageal cancer.
  • We discuss the imaging appearances of this tumour on positron emission tomography combined with computed tomography (PET/CT) and magnetic resonance imaging.
  • [MeSH-major] Fibromatosis, Aggressive / diagnosis. Neoplasms, Second Primary / diagnosis
  • [MeSH-minor] Aged. Biopsy. Diagnosis, Differential. Female. Fluorodeoxyglucose F18. Humans. Magnetic Resonance Imaging. Positron-Emission Tomography. Radiopharmaceuticals. Thoracic Wall

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AJR Am J Roentgenol. 1999 Apr;172(4):1149 [10587179.001]
  • [Cites] Eur J Cardiothorac Surg. 2001 May;19(5):580-3 [11343935.001]
  • [Cites] Radiographics. 2003 Nov-Dec;23(6):1477-90 [14615559.001]
  • [Cites] Radiographics. 2003 Nov-Dec;23(6):1491-508 [14615560.001]
  • [Cites] AJR Am J Roentgenol. 2004 Jul;183(1):35-7 [15208104.001]
  • [Cites] AJR Am J Roentgenol. 1977 Sep;129(3):524-5 [409215.001]
  • [Cites] Radiology. 2007 Dec;245(3):839-47 [18024454.001]
  • [Cites] Cancer. 1992 May 15;69(10):2478-83 [1568169.001]
  • [Cites] Ann Thorac Surg. 1997 Jan;63(1):214-9 [8993268.001]
  • [Cites] Kyobu Geka. 1998 Nov;51(12):1055-9 [9838789.001]
  • [Cites] Semin Nucl Med. 2005 Apr;35(2):84-99 [15765372.001]
  • [Cites] Br J Radiol. 2007 Jul;80(955):574-80 [16728417.001]
  • [Cites] Br J Radiol. 2007 Sep;80(957):750-6 [17709361.001]
  • [Cites] Cancer. 1983 Dec 15;52(12):2201-4 [6640490.001]
  • (PMID = 20139256.001).
  • [ISSN] 1748-880X
  • [Journal-full-title] The British journal of radiology
  • [ISO-abbreviation] Br J Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  • [Other-IDs] NLM/ PMC3473531
  •  go-up   go-down


83. Tejpar S, Michils G, Denys H, Van Dam K, Nik SA, Jadidizadeh A, Cassiman JJ: Analysis of Wnt/Beta catenin signalling in desmoid tumors. Acta Gastroenterol Belg; 2005 Jan-Mar;68(1):5-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Analysis of Wnt/Beta catenin signalling in desmoid tumors.
  • Desmoid tumors are fibromatous lesions occurring both sporadically and in patients with familial adenomatous polyposis (FAP).
  • Because of the association of these tumors with the hereditary colorectal cancer syndrome FAP we set out to define the molecular events driving desmoid tumorigenesis, hypothezising these might be identical to events driving colorectal tumorigenesis.
  • We found that whereas FAP-associated desmoid tumors are caused by germline APC mutations followed by somatic inactivation of the wild-type APC allele, sporadic desmoids are usually characterized by oncogenic mutations in the b-catenin gene, both identical molecular alterations to those found in the vast majority of colorectal cancers.
  • Next we set out to investigate the cellular pathways activated by these mutations, and identified activation of the Wnt signaling pathway in desmoid tumors.
  • Currently we are investigating tissue-specific downstream effectors of the Wnt pathway that might be responsible for the behaviour of these invasive fibrous tumors.
  • Our findings also point to a role for this pathway in the regulation of normal myofibroblast proliferation and suggest novel treatments in desmoid tumors and other fibrous proliferative disorders.
  • [MeSH-major] Adenomatous Polyposis Coli / genetics. Cytoskeletal Proteins / genetics. Fibromatosis, Aggressive / genetics. Genetic Predisposition to Disease. Polymorphism, Genetic. Trans-Activators / genetics

  • Genetics Home Reference. consumer health - APC gene.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15832580.001).
  • [ISSN] 1784-3227
  • [Journal-full-title] Acta gastro-enterologica Belgica
  • [ISO-abbreviation] Acta Gastroenterol. Belg.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Review
  • [Publication-country] Belgium
  • [Chemical-registry-number] 0 / CTNNB1 protein, human; 0 / Cytoskeletal Proteins; 0 / Trans-Activators; 0 / beta Catenin
  • [Number-of-references] 20
  •  go-up   go-down


84. Soufi M, Lahlou MK, Bensaid M, Messrouri R, Benamer S, Essadel A, Mdaghri J, Mohammadine E, Taghy A, Settaf A, Chad B: [Desmoid tumors of the abdominal wall: three cases]. Rev Med Liege; 2009 Dec;64(12):633-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Desmoid tumors of the abdominal wall: three cases].
  • [Transliterated title] Les tumeurs desmoïdes de la paroi abdominale. A propos de trois cas.
  • Desmoids tumors are rare.
  • They often develop from the fascia and muscles of the abdominal wall.
  • They are considered as benign, but endowed with local aggressiveness.
  • WE report three cases of histology proven desmoids tumors of the abdominal wall treated between 2000 and 2007.
  • Etiologic factors, diagnosis, surgical management and adjuvant therapy in case of incomplete resection or reccurrence are discussed.
  • [MeSH-major] Abdominal Wall / surgery. Fibromatosis, Aggressive / pathology. Fibromatosis, Aggressive / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20143748.001).
  • [ISSN] 0370-629X
  • [Journal-full-title] Revue médicale de Liège
  • [ISO-abbreviation] Rev Med Liege
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Belgium
  •  go-up   go-down


85. Soon JL, Lau WK, Seow-Choen F, Cheng CW: Unresectable desmoid tumours causing obstructive uropathy in familial adenomatous polyposis. Asian J Surg; 2005 Jul;28(3):233-7
Genetic Alliance. consumer health - Familial Polyposis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unresectable desmoid tumours causing obstructive uropathy in familial adenomatous polyposis.
  • Desmoid tumour-related ureteral obstruction in familial adenomatous polyposis presents difficult management problems.
  • Both our patients developed intra-abdominal desmoid tumours following proctocolectomies with pouch reconstruction (performed 0.7 and 2.5 years earlier).

  • Genetic Alliance. consumer health - Familial Adenomatous Polyposis (FAP).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16024324.001).
  • [ISSN] 1015-9584
  • [Journal-full-title] Asian journal of surgery
  • [ISO-abbreviation] Asian J Surg
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] China
  • [Number-of-references] 12
  •  go-up   go-down


86. Zisis C, Dountsis A, Nikolaides A, Dahabreh J: Desmoid tumors of the chest wall. Asian Cardiovasc Thorac Ann; 2006 Oct;14(5):359-62

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoid tumors of the chest wall.
  • Chest wall desmoid tumors (DT) are rare pathologic entities with microscopic features similar to, or undistinguishable from, fibromas or fibrosarcomas.
  • A resection of the lesion was performed with negative margins of 4 cm around the tumor (wide resection).
  • One patient had a recurrence 15 months later, and was admitted for complementary resection, and remains disease-free for 5 years.
  • The rest 3 patients are disease-free for 6 months to 5 years.
  • Resection must include all adjacent, overlying and underlying musculature as well as soft tissues and any spare skin from the procedure should be used.
  • [MeSH-major] Fibromatosis, Aggressive / surgery. Neoplasm Recurrence, Local / surgery. Soft Tissue Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17005879.001).
  • [ISSN] 1816-5370
  • [Journal-full-title] Asian cardiovascular & thoracic annals
  • [ISO-abbreviation] Asian Cardiovasc Thorac Ann
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biocompatible Materials
  •  go-up   go-down


87. Okamoto K, Kurihara Y, Imamura K, Kanemaki Y, Nakajima Y, Fukuda M, Maeda I: Desmoid tumor of the breast: the role of proton magnetic resonance spectroscopy for a benign breast lesion mimicking a malignancy. Breast J; 2008 Jul-Aug;14(4):376-8
MedlinePlus Health Information. consumer health - Breast Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoid tumor of the breast: the role of proton magnetic resonance spectroscopy for a benign breast lesion mimicking a malignancy.
  • Desmoid tumor of the breast is an extremely rare condition.
  • It is difficult to provide a correct preoperative diagnosis of desmoid tumor of the breast because of its tendency to mimic breast carcinoma on physical examination and conventional imaging such as mammography and sonography.
  • We present a case of desmoid tumor of the breast that mimicked breast carcinoma, in which proton magnetic resonance spectroscopy assisted the result of biopsy, thus enabling a correct preoperative diagnosis.
  • [MeSH-major] Breast Neoplasms / diagnosis. Fibromatosis, Aggressive / diagnosis. Magnetic Resonance Spectroscopy
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Protons

  • Genetic Alliance. consumer health - Desmoid Tumor.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18687071.001).
  • [ISSN] 1524-4741
  • [Journal-full-title] The breast journal
  • [ISO-abbreviation] Breast J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Protons
  •  go-up   go-down


88. Wong SL: Diagnosis and management of desmoid tumors and fibrosarcoma. J Surg Oncol; 2008 May 1;97(6):554-8
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnosis and management of desmoid tumors and fibrosarcoma.
  • Fibrous tumors represent a diverse subtype of soft tissue tumors and can represent benign conditions as well as frankly malignant sarcomas.
  • Desmoid tumors and dermatofibrosarcoma protuberans are more difficult to classify and tend to be considered in the intermediate risk category.
  • They are distinct entities, but both are locally aggressive processes which are plagued with attendant morbidity and high recurrence rates.
  • [MeSH-major] Fibromatosis, Aggressive / diagnosis. Fibromatosis, Aggressive / therapy. Fibrosarcoma / diagnosis. Fibrosarcoma / therapy

  • Genetic Alliance. consumer health - Fibrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 Wiley-Liss, Inc.
  • (PMID = 18425778.001).
  • [ISSN] 0022-4790
  • [Journal-full-title] Journal of surgical oncology
  • [ISO-abbreviation] J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 37
  •  go-up   go-down


89. Güzey FK, Emel E, Bas NS, Ozkan N, Turgut H, Sel B: Aggressive postoperative lumbar fibromatosis after the placement of instrumentation for treatment of spondylolisthesis. Case report. J Neurosurg Spine; 2006 Apr;4(4):338-41
Genetic Alliance. consumer health - Fibromatosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Aggressive postoperative lumbar fibromatosis after the placement of instrumentation for treatment of spondylolisthesis. Case report.
  • This 50-year-old woman presented with a paravertebral lumbar fibromatosis (desmoid tumor) after undergoing the placement of instrumentation for lumbar spondylolisthesis.
  • The tumor developed just cranial to the previous skin incision.
  • Fibromatoses, or desmoid tumors, are uncommon infiltrative lesions that affect musculoaponeurotic structures, most often of the trunk and limbs.
  • In cases involving well-defined tumors in which radical resection is possible, surgery is the treatment of choice; however, the recurrence rate is high.
  • Although rare, this distinctive tumor should be considered in the differential diagnosis of postoperative paravertebral bulgings after neurosurgical and spinal operations.
  • [MeSH-major] Fibromatosis, Aggressive / pathology. Soft Tissue Neoplasms / pathology. Spondylolisthesis / surgery

  • Genetic Alliance. consumer health - Aggressive Fibromatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16619683.001).
  • [ISSN] 1547-5654
  • [Journal-full-title] Journal of neurosurgery. Spine
  • [ISO-abbreviation] J Neurosurg Spine
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


90. Oudidi A, Hachimi H, El Alami MN: [Desmoid tumor of the parotid gland]. Rev Stomatol Chir Maxillofac; 2006 Dec;107(6):470-3
Genetic Alliance. consumer health - Desmoid Tumor.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Desmoid tumor of the parotid gland].
  • [Transliterated title] Tumeur desmoïde de la glande parotide.
  • INTRODUCTION: Desmoid tumor is a benign microscopic tumor that belongs to the group of the deep fibromatosis.
  • It usually arises from facial or musculoaponeurotic structures in the abdomen but rarely is located in the head or neck.
  • Physical examination revealed a tumor in the parotid gland, which was hard and adherent deeply, measuring 4 cm/3 cm and sensitive to palpation; without satellite nodes nor facial paralysis.
  • Pathology was in favor of a desmoid tumor.
  • DISCUSSION: Desmoid tumors are deep fibromatosis characterized by their slow growth and especially by considerable infiltration of the adjacent structures but without potential for metastasis.
  • Although very rare, the cervical localizations are especially aggressive.
  • [MeSH-major] Fibromatosis, Aggressive / pathology. Parotid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17195002.001).
  • [ISSN] 0035-1768
  • [Journal-full-title] Revue de stomatologie et de chirurgie maxillo-faciale
  • [ISO-abbreviation] Rev Stomatol Chir Maxillofac
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


91. Castellazzi G, Vanel D, Le Cesne A, Le Pechoux C, Caillet H, Perona F, Bonvalot S: Can the MRI signal of aggressive fibromatosis be used to predict its behavior? Eur J Radiol; 2009 Feb;69(2):222-9
MedlinePlus Health Information. consumer health - MRI Scans.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Can the MRI signal of aggressive fibromatosis be used to predict its behavior?
  • PURPOSE: Aggressive fibromatosis is an invasive non-metastasizing soft-tissue tumor.
  • The aim of this study was to analyze and correlate the size and MR imaging signal features of aggressive fibromatosis with its behavior in order to choose the best treatment.
  • CONCLUSION: Fibromatoses are a group of soft-tissue tumors with variable characteristics on MRI, but it is not possible to predict their behavior based on the MRI signal.
  • [MeSH-major] Fibromatosis, Aggressive / diagnosis. Magnetic Resonance Imaging / methods. Soft Tissue Neoplasms / diagnosis

  • Genetic Alliance. consumer health - Aggressive Fibromatosis.
  • Genetic Alliance. consumer health - Fibromatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19046842.001).
  • [ISSN] 1872-7727
  • [Journal-full-title] European journal of radiology
  • [ISO-abbreviation] Eur J Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  •  go-up   go-down


92. Sciallis GF, Sciallis AP: Becker nevus with an underlying desmoid tumor: a case report and review including Mayo Clinic's experience. Arch Dermatol; 2010 Dec;146(12):1408-12
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Becker nevus with an underlying desmoid tumor: a case report and review including Mayo Clinic's experience.
  • Our objectives were to report the occurrence of a Becker nevus with an underlying desmoid soft-tissue tumor; to review Mayo Clinic's experience with Becker nevi, concentrating on Becker nevi associated with bone, vascular, neural, and other soft-tissue abnormalities; to inform physicians of the Becker nevus syndrome; and finally to alert clinicians to evaluate a Becker nevus with its associations in mind.
  • OBSERVATIONS: A 46-year-old woman had a Becker nevus with an underlying desmoid-type fibromatosis (desmoid tumor) presenting clinically as a "painful dimple" within the nevus.
  • Review of medical records for 1997 through 2006 at Mayo Clinic, Rochester, Minnesota, yielded 52 patients with Becker nevi, 12 of whom had an associated bone, vascular, neural, congenital, or other soft-tissue abnormality, ranging from liposarcoma to an accessory areola.
  • CONCLUSIONS: We add to the literature a unique case of desmoid-type fibromatosis immediately beneath a Becker melanosis, which presented as a painful dimple.
  • We hope to raise awareness that a Becker nevus may be associated with other abnormalities, including an infiltrative soft-tissue tumor.
  • We also emphasize the importance of follow-up, including inspection of not only the surface but also the deep tissues underlying the Becker nevus.
  • [MeSH-major] Fibromatosis, Aggressive / diagnosis. Neoplasms, Multiple Primary / diagnosis. Nevus, Pigmented / diagnosis. Skin Neoplasms / diagnosis. Soft Tissue Neoplasms / diagnosis
  • [MeSH-minor] Arm. Back. Diagnosis, Differential. Female. Humans. Magnetic Resonance Imaging. Middle Aged. Syndrome

  • Genetic Alliance. consumer health - Desmoid Tumor.
  • Genetic Alliance. consumer health - Nevus.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21173323.001).
  • [ISSN] 1538-3652
  • [Journal-full-title] Archives of dermatology
  • [ISO-abbreviation] Arch Dermatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


93. Colović R, Radak V, Micev M, Colović N: [Desmoid tumor within lesser sac]. Srp Arh Celok Lek; 2006 Sep-Oct;134(9-10):438-40
Genetic Alliance. consumer health - Desmoid Tumor.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Desmoid tumor within lesser sac].
  • Desmoid tumors or fibromatoses comprise a number of benign fibrous proliferative lesions that have local infiltrative growth and tendency to recur after incomplete excision.
  • Compressing the splenic vein, the tumor caused left-sided portal hypertension which subsided after the mass was removed.
  • The histological examination verified typical desmoid tumor.
  • [MeSH-major] Fibromatosis, Aggressive. Peritoneal Neoplasms

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17252913.001).
  • [ISSN] 0370-8179
  • [Journal-full-title] Srpski arhiv za celokupno lekarstvo
  • [ISO-abbreviation] Srp Arh Celok Lek
  • [Language] srp
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Serbia and Montenegro
  •  go-up   go-down


94. Fimmanò A, Coppola Bottazzi E, Cirillo C, Tammaro P, Casazza D: [Desmoid tumor of the chest wall foiling surgery]. Ann Ital Chir; 2006 Mar-Apr;77(2):169-72; discussion 172
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Desmoid tumor of the chest wall foiling surgery].
  • [Transliterated title] Desmoide della parete toracica, ad insorgenza postchirurgica.
  • CASE REPORT: The patient was subjected to laboratory tests, which showed nothing pathological, and to instrumental tests (RX and TAC of the chest, bony scintigraphy) which showed a roundish solid tumefaction, with no "secondary" interest of bony tissue.
  • The anatomo-pathological test showed a desmoid fibromatosis (desmoid tumor) extra-abdominal (12.5 x 9 x 5 cm).
  • [MeSH-major] Fibromatosis, Aggressive / surgery. Thoracic Wall
  • [MeSH-minor] Female. Follow-Up Studies. Humans. Middle Aged. Neoplasm Recurrence, Local / surgery. Thoracotomy. Time Factors

  • Genetic Alliance. consumer health - Desmoid Tumor.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17147093.001).
  • [ISSN] 0003-469X
  • [Journal-full-title] Annali italiani di chirurgia
  • [ISO-abbreviation] Ann Ital Chir
  • [Language] ita
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


95. Seinfeld J, Kleinschmidt-DeMasters BK, Tayal S, Lillehei KO: Desmoid-type fibromatosis involving the brachial plexus. Neurosurg Focus; 2007;22(6):E22
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoid-type fibromatosis involving the brachial plexus.
  • Desmoid-type fibromatosis involving the brachial plexus is a rare and challenging disease.
  • The authors describe their experience in four surgically treated patients with desmoid-type fibromatosis involving the brachial plexus and review the relevant neurosurgical literature.
  • All tumors were assessed for c-KIT oncogene mutations in hopes of establishing a biological basis for using the tyrosine kinase inhibitor imatimib mesylate as an adjuvant therapy.
  • Three patients experienced tumor recurrence requiring reoperation.
  • Fractionated radiotherapy achieved local control in three patients, and the disease in one patient progressed beyond the treatment field.
  • Single base pair changes at exon 10 of the c-KIT oncogene were identified in three tumors.
  • One tumor with this mutation did not respond to treatment with imatimib mesylate.
  • Analysis of these cases emphasizes the need for careful resection in patients with desmoid-type fibromatosis and supports the conclusion that without adjuvant radiotherapy a high local recurrence rate can be anticipated.
  • For optimal local disease control, the authors recommend postsurgical radiation therapy regardless of the extent of resection achieved.
  • [MeSH-major] Brachial Plexus / pathology. Brachial Plexus / surgery. Fibromatosis, Abdominal / radiotherapy. Fibromatosis, Abdominal / surgery
  • [MeSH-minor] Adult. Aged. Female. Fibromatosis, Aggressive / diagnosis. Fibromatosis, Aggressive / radiotherapy. Fibromatosis, Aggressive / surgery. Humans. Male. Middle Aged. Retrospective Studies. Treatment Outcome

  • Genetic Alliance. consumer health - Fibromatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17613214.001).
  • [ISSN] 1092-0684
  • [Journal-full-title] Neurosurgical focus
  • [ISO-abbreviation] Neurosurg Focus
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


96. Maeda R, Isowa N, Onuma H, Miura H, Tokuyasu H, Kawasaki Y: Desmoid tumor of the chest wall in an elderly woman. Gen Thorac Cardiovasc Surg; 2009 Oct;57(10):554-7
Genetic Alliance. consumer health - Desmoid Tumor.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoid tumor of the chest wall in an elderly woman.
  • We report a case of desmoid tumor of the chest wall in a 79-year-old woman.
  • Magnetic resonance imaging of the chest revealed a soft tissue tumor in the right lateral chest wall with unclear margins that extended into the intercostal muscles.
  • Because open biopsy suggested a desmoid tumor, full-thickness chest wall resection with reconstruction was performed.
  • The final diagnosis was desmoid tumor of the chest wall.
  • Wide surgical resection during the initial operation is an essential element in the treatment of this tumor.
  • [MeSH-major] Fibromatosis, Aggressive / diagnosis. Intercostal Muscles / pathology. Ribs / pathology. Thoracic Neoplasms / diagnosis. Thoracic Wall / pathology
  • [MeSH-minor] Aged. Biopsy. Female. Fluorodeoxyglucose F18. Humans. Magnetic Resonance Imaging. Neoplasm Invasiveness. Positron-Emission Tomography. Radiopharmaceuticals. Thoracotomy. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19830521.001).
  • [ISSN] 1863-6713
  • [Journal-full-title] General thoracic and cardiovascular surgery
  • [ISO-abbreviation] Gen Thorac Cardiovasc Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


97. Lakhan SE, Eager RM, Harle L: Aggressive juvenile fibromatosis of the paranasal sinuses: case report and brief review. J Hematol Oncol; 2008;1:3
Genetic Alliance. consumer health - Fibromatosis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Aggressive juvenile fibromatosis of the paranasal sinuses: case report and brief review.
  • Desmoid fibromatoses are benign, slow growing fibroblastic neoplasms, arising from musculoaponeurotic stromal elements.
  • Desmoids are characterized by local invasion, with a high rate of local recurrence and a tendency to destroy adjacent structures and organs.
  • Desmoid fibromatoses are rare in children, and though they may occur in the head and neck region, are extremely rare in the paranasal sinuses.
  • Here we report a case of extraabdominal desmoid fibromatosis in a seven-year-old boy involving the sphenoid sinus, one of only six published reports of desmoid fibromatosis of the paranasal sinuses.
  • The expansile soft tissue mass eroded the walls of the sphenoid sinus as well as the posterior ethmoid air cells extending cephalad through the base of the skull.
  • [MeSH-major] Fibromatosis, Aggressive / pathology. Paranasal Sinus Neoplasms / pathology

  • Genetic Alliance. consumer health - Aggressive Fibromatosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1999 Nov 15;86(10):2045-52 [10570430.001]
  • [Cites] J Clin Oncol. 1999 Jan;17(1):158-67 [10458229.001]
  • [Cites] J Surg Oncol. 2000 Jan;73(1):21-5 [10649274.001]
  • [Cites] Cancer. 2000 Apr 1;88(7):1517-23 [10738207.001]
  • [Cites] Clin Orthop Relat Res. 2000 Jun;(375):207-13 [10853171.001]
  • [Cites] Mod Pathol. 2000 Oct;13(10):1080-5 [11048801.001]
  • [Cites] Cancer. 2001 Sep 1;92(5):1259-64 [11571741.001]
  • [Cites] Acta Orthop Scand. 2002 Apr;73(2):213-9 [12079022.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):177-181 [12182989.001]
  • [Cites] Cancer. 2002 Dec 1;95(11):2373-9 [12436445.001]
  • [Cites] Ann Oncol. 2003 Feb;14(2):181-90 [12562642.001]
  • [Cites] Cancer. 2003 Feb 15;97(4):1134-5 [12569616.001]
  • [Cites] J Clin Oncol. 2003 Apr 1;21(7):1390-7 [12663732.001]
  • [Cites] Cancer. 2004 Feb 1;100(3):612-20 [14745880.001]
  • [Cites] Int J Oral Maxillofac Surg. 2004 Sep;33(6):606-9 [15308262.001]
  • [Cites] Ear Nose Throat J. 2004 Jul;83(7):481-4 [15372920.001]
  • [Cites] Ann Thorac Surg. 2004 Oct;78(4):1219-23; discussion 1219-23 [15464474.001]
  • [Cites] Am J Surg. 1966 Oct;112(4):609-14 [5915309.001]
  • [Cites] Cancer. 1976 Jun;37(6):2912-28 [949712.001]
  • [Cites] Klin Padiatr. 1999 Jul-Aug;211(4):291-5 [10472564.001]
  • [Cites] Onkologie. 2004 Dec;27(6):552-6 [15591714.001]
  • [Cites] Cancer. 2005 Sep 1;104(5):1090-9 [16015632.001]
  • [Cites] J Clin Oncol. 2006 Mar 1;24(7):1195-203 [16505440.001]
  • [Cites] J Clin Oncol. 2007 Feb 10;25(5):501-6 [17290057.001]
  • [Cites] J Clin Oncol. 2007 May 1;25(13):1785-91 [17470870.001]
  • [Cites] Cancer Res. 2007 Aug 1;67(15):7124-31 [17671179.001]
  • [Cites] Am J Clin Pathol. 1982 Jun;77(6):665-73 [7091046.001]
  • [Cites] Arch Surg. 1983 Nov;118(11):1318-22 [6639341.001]
  • [Cites] Arch Surg. 1989 Feb;124(2):191-6 [2916941.001]
  • [Cites] Cancer. 1989 Sep 15;64(6):1192-4 [2766217.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1990 Mar;18(3):535-40 [2318685.001]
  • [Cites] Am J Surg. 1991 Apr;161(4):416-21 [2035759.001]
  • [Cites] Otolaryngol Head Neck Surg. 1991 Apr;104(4):549-52 [1903871.001]
  • [Cites] Ear Nose Throat J. 1991 Jul;70(7):462-8 [1914969.001]
  • [Cites] Dis Colon Rectum. 1992 Jan;35(1):29-33 [1310270.001]
  • [Cites] Cancer. 1992 May 15;69(10):2478-83 [1568169.001]
  • [Cites] Eur J Cancer. 1992;28A(6-7):1014-8 [1385717.001]
  • [Cites] J Clin Gastroenterol. 1993 Apr;16(3):264-5 [8505507.001]
  • [Cites] Cancer. 1993 Sep 1;72(5):1637-41 [8348495.001]
  • [Cites] Cancer. 1993 Dec 1;72(11):3244-7 [8242548.001]
  • [Cites] Dis Colon Rectum. 1994 Mar;37(3):260-7 [8137673.001]
  • [Cites] Cancer Genet Cytogenet. 1995 Feb;79(2):139-43 [7889507.001]
  • [Cites] Br J Surg. 1995 Apr;82(4):510-4 [7613897.001]
  • [Cites] J Clin Oncol. 1995 Nov;13(11):2813-8 [7595743.001]
  • [Cites] Int J Cancer. 1995 Nov 15;63(4):527-9 [7591262.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1996 Jun;105(6):463-6 [8638898.001]
  • [Cites] Cancer. 1996 Mar 15;77(6):1061-5 [8635124.001]
  • [Cites] Urology. 1996 May;47(5):756-9 [8650880.001]
  • [Cites] Cancer Genet Cytogenet. 1996 Dec;92(2):147-9 [8976373.001]
  • [Cites] Cancer. 1997 Jul 15;80(2):334-40 [9217047.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1997 Oct 1;39(3):659-65 [9336146.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1998 Feb 1;40(3):637-45 [9486614.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1998 Dec 1;42(5):1007-14 [9869223.001]
  • [Cites] J Clin Oncol. 1999 Mar;17(3):1086 [10071306.001]
  • [Cites] Am J Pathol. 1999 Mar;154(3):729-33 [10079250.001]
  • [Cites] Acta Oncol. 1999;38(7):971-2 [10606429.001]
  • (PMID = 18577255.001).
  • [ISSN] 1756-8722
  • [Journal-full-title] Journal of hematology & oncology
  • [ISO-abbreviation] J Hematol Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2438440
  •  go-up   go-down


98. Mayer M, Kulig A, Sygut J, Dziki A, Simon D, Latos-Bieleńska A, Ferenc T: Molecular cytogenetic analysis of chromosome aberrations in desmoid tumors. Pol J Pathol; 2007;58(3):167-71

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Molecular cytogenetic analysis of chromosome aberrations in desmoid tumors.
  • To date there are only few reports concerning chromosomal changes in desmoid tumors.
  • To extend the knowledge in this field we examined 19 samples from the patients diagnosed with desmoid tumors.
  • In the present study formalin-fixed and paraffin-embedded desmoid tumors were analyzed using fluorescence in situ hybridization (FISH) with a-satellite probes for chromosomes X, Y, 8 and 20.
  • Chromosomal abnormalities were found in 6 cases, both abdominal and extra-abdominal tumors.
  • Our findings confirm earlier reports concerning the diversity of chromosomal changes in desmoid tumors and might suggest that both groups of abdominal and extra-abdominal tumors are genuine neoplasms.
  • [MeSH-major] Chromosome Aberrations. Cytogenetic Analysis. Fibromatosis, Aggressive / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18074861.001).
  • [ISSN] 1233-9687
  • [Journal-full-title] Polish journal of pathology : official journal of the Polish Society of Pathologists
  • [ISO-abbreviation] Pol J Pathol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Poland
  •  go-up   go-down


99. Ishizuka M, Hatori M, Dohi O, Suzuki T, Miki Y, Tazawa C, Sasano H, Kokubun S: Expression profiles of sex steroid receptors in desmoid tumors. Tohoku J Exp Med; 2006 Nov;210(3):189-98
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression profiles of sex steroid receptors in desmoid tumors.
  • Desmoid tumors are benign fibrous neoplasms which arise from the fibrous tissue of intra- and extra- abdominal sites, but their clinical management is sometimes difficult because of extensive infiltration into the surrounding tissues.
  • Desmoid tumors commonly occur in women, especially after childbirth.
  • Recently, both clinical and experimental findings indicate the possible roles of sex steroids in the development and progression of desmoid tumors but detailed information is still ambiguous.
  • In this study, we first examined immunoreactivity of sex steroid receptors in desmoid tumors (27 cases) by immunohistochemistry and compared the findings with those in reactive self-limiting lesions associated with fibrosis (8 cases).
  • Estrogen receptor (ER) alpha and ERbeta immunoreactivities were detected in 7.4% (2/27) and 7.4% (2/27) of desmoid tumors, respectively.
  • One desmoid tumor expressed both ERalpha and ERbeta.
  • Sex steroid receptor mRNAs was further examined by reverse transcription and polymerase chain reaction (RT-PCR) analysis using fresh frozen tissues, demonstrating the expression of PR (PR-A and/or PR-B) and AR mRNAs in eight desmoid tumors examined and all cases of reactive fibrosis.
  • These results indicate that sex steroid hormones might play an important role in the pathogenesis of desmoid tumors and could lead to the introduction of novel hormone therapeutic approaches in managing patients with recurrent desmoid tumors.
  • [MeSH-major] Fibromatosis, Aggressive / metabolism. Gene Expression Regulation, Neoplastic. Neoplasms / metabolism. Receptors, Steroid / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17077595.001).
  • [ISSN] 0040-8727
  • [Journal-full-title] The Tohoku journal of experimental medicine
  • [ISO-abbreviation] Tohoku J. Exp. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Estrogen Receptor alpha; 0 / Estrogen Receptor beta; 0 / Receptors, Progesterone; 0 / Receptors, Steroid
  •  go-up   go-down


100. Carneiro C, Hurtubis C, Singh M, Robinson W: Desmoid tumors of the right rectus abdominus muscle in postpartum women. Arch Gynecol Obstet; 2009 Jun;279(6):869-73
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoid tumors of the right rectus abdominus muscle in postpartum women.
  • BACKGROUND: Desmoid tumors are benign neoplasms that most often arise from muscle aponeurosis and have been associated with both trauma and pregnancy.
  • The etiology of desmoids has not been determined.
  • CLINICAL CHARACTERISTICS: We present here four almost identical cases with desmoids occurring in the same location, the right rectus abdominus muscle in young post partum females.
  • All were over the age of 30 at the time of diagnosis.
  • DISCUSSION: All four patients are disease free at a median follow-up of 2.5 years.
  • The possible etiology of desmoids tumors in this location in postpartum females is discussed.
  • [MeSH-major] Fibromatosis, Abdominal / pathology. Muscle Neoplasms / pathology. Rectus Abdominis / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19020890.001).
  • [ISSN] 1432-0711
  • [Journal-full-title] Archives of gynecology and obstetrics
  • [ISO-abbreviation] Arch. Gynecol. Obstet.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down






Advertisement